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Abstract
This survey study investigated attitudes and practices of 161 licensed psychologists from
a nationwide sample, relative to addressing negative effects of psychotherapy during the
informed consent process. Results revealed discrepancies in attitudes toward risk of
negative treatment effects in psychotherapy and in addressing risk during the process of
informed consent. Information obtained from this study may contribute to research in the
area of clinical implementation of the American Psychological Association’s Code of
Ethics. Implications for clinical practice are discussed. Limitations of the study and
directions for future research are also addressed.

v
Table of Contents
Acknowledgements ........................................................................................................ iii
Abstract .......................................................................................................................... iv
Table of Contents ............................................................................................................ v
List of Tables ................................................................................................................ vii
Chapter One: Introduction .............................................................................................. 1
Statement of the Problem ............................................................................................ 1
Purpose of the Study ................................................................................................... 4
Relevance to Cognitive Behavior Therapy ................................................................. 6
Overview of Literature Review .................................................................................. 7
Chapter Two: Review of the Literature .......................................................................... 9
Defining Important Terms .......................................................................................... 9
Psychotherapy Failure versus Treatment That May Cause Harm ............................ 14
Informed Consent Underpinning .............................................................................. 18
Informed Consent Historical Factors ........................................................................ 21
Informed Consent Functions ..................................................................................... 33
The Ethics Codes ...................................................................................................... 35
Informed Consent and Implementation .................................................................... 40
Informed Consent and Risk ...................................................................................... 46
Informed Consent Biases .......................................................................................... 50
Chapter Three: Hypotheses ........................................................................................... 57
Specific Hypotheses and Questions .......................................................................... 57
Chapter Four: Method ................................................................................................... 60

vi
Overview ................................................................................................................... 60
Design and Design Justification................................................................................ 60
Participants ................................................................................................................ 61
Measures ................................................................................................................... 62
Procedure .................................................................................................................. 63
Chapter Five: Results .................................................................................................... 65
Demographic Information on the Study Sample ...................................................... 65
Frequent Attitudes Endorsed in the Study Sample ................................................... 72
Results of Hypotheses Testing .................................................................................. 85
Chapter Six: Discussion ................................................................................................ 89
Summary of the Study Rationale .............................................................................. 89
Demographic Information ......................................................................................... 90
Relationship between Attitude and Practice ............................................................. 91
Implications for Informed Consent Practice ............................................................. 95
Limitations and Implication for Future Research ................................................... 100
Conclusion .............................................................................................................. 102
References ................................................................................................................... 104

vii
List of Tables

Table 1. Demographic Characteristics of the Sample

68

Table 2. Frequent Attitudes Endorsed Survey Questionnaire

76

Table 3. Frequent Attitudes Endorsed Survey Questionnaire

82

Table 4. Frequent Attitudes Endorsed Survey Questionnaire

83

Table 5. Frequent Attitudes Endorsed Survey Questionnaire

84

Chapter One: Introduction
Statement of the Problem
Psychotherapy has the potential to produce a plethora of positive and negative
effects. Lilienfeld (2007) listed several of these potentially negative effects of
psychotherapy, including “symptom worsening, the appearance of new symptoms,
heightened concern regarding existing symptoms, excessive dependency on therapists,
reluctance to seek future treatment (Boisvert & Faust, 2003), and even physical harm,”
(Mercer, Sarner, & Rosa, 2003, p.56). Research suggests that a significant minority of
clients experience negative effects, including iatrogenic and/or deterioration effects as a
result of psychotherapy (Boisvert & Faust, 2002). Data suggest a failure rate that
approaches one-third, and a rate of deterioration, with estimates ranging from 3 to 10
percent (Bergin, 1971; Strupp, Hadley, & Gomes-Schwartz, 1977; Mohr, 1995; Stricker,
1995; Lambert & Ogles, 2004; Lilienfeld, 2007). Estimates of client deterioration are
higher in the substance abuse literature, averaging about 10 to 15 percent (Ilgen & Moos,
2005; Moos, 2005). Among group psychotherapy, Leiberman and Yalom (1973) reveal
“a negative change figure of 16 percent that include 8 percent casualties,” in which
casualties were defined as “an enduring (8 months or more), significant negative
outcome, which was caused by [an individual's] participation in the group” (as cited in
Roback, 2000, p. 1). A survey study of negative outcome published in 1981 (Buckley,
Karasu, & Charles) revealed that 21 percent of mental health professionals endorsed
harmful outcomes as a result of engaging in their own personal psychotherapy. In a
review of two meta-analyses, Mohr (1995) found 9 to 13 percent of studies produced
negative effect sizes for psychotherapy outcome in the negative direction (Smith, Glass,
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& Miller, 1980; Shapiro & Shapiro, 1982), suggesting negative effects as a result of
therapy. Results from an international survey of 12 leading psychotherapy outcome
researchers concluded that “approximately 10 percent of clients get worse as a result of
therapy” (Boisvert & Faust, 2003, p. 512). Considering the number of individuals who
engage in psychotherapy every year, this is not an insignificant statistic (Olfson, Marcus,
Druss, & Pincus, 2002).
The idea that psychotherapy has the latent ability to produce negative effects has
potential implications for informed consent. Due to the multidimensionality of
potentially negative effects of psychotherapy, assessing psychologists' attitudes regarding
risk toward iatrogenic and deterioration effects may be an important indicator of what is
considered material to a client's decision during the informed consent process. Informing
clients about the potential risks and benefits of psychotherapy is a fundamental
component of obtaining informed consent, analogous to a physician’s informing a patient
about the risks and benefits of medication or treatment.
The current American Psychological Association's (APA) Ethical Principles of
Psychologists and Code of Conduct (2002), (hereinafter, Ethics Code) include broad
guidelines regarding the process of obtaining informed consent to therapy. Ethical
standard 10.01b states that for some treatments it is also necessary to “inform
clients/patients of the developing nature of the treatment, the potential risks involved,
[and] alternative treatments that may be available” (APA, 2002, p. 1072). Although
“particularly stringent consent procedures,” Barden (2001) notes, “should apply to
'treatments' lacking rigorous, empirical evidence of safety and efficacy,” all forms of
psychotherapy “irrefutably fall within the scope of patient's rights to informed consent”
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(p. 160). Psychologists are also ethically obligated to obtain informed consent to
psychotherapy “as early as feasible” (APA, 2002, p. 1072). It is consistent with the
fundamental concepts of informed consent to discuss with prospective clients that therapy
may not work for them and that there is a risk, although somewhat small, of negative
effects when engaging in psychotherapy (Boisvert & Faust, 2003; APA, 2002). Risks are
thought to be material when a reasonable person in the client’s position, “would likely
attach significance to the risk or cluster of risks in question in deciding whether or not to
forgo the proposed therapy (Canterbury v. Spence, 1972, p. 787)” (as cited in Noll, 1981,
p. 915). To neglect potential risk of negative effects during the informed consent process
imposes serious ethical and moral questions (Noll, 1981). There is no “normative data
for what a reasonable person understands in various consent situations (e.g., high versus
low risk with high versus low individual benefit)” (Tymchuk, 1997, p. 58). Although
psychologists might occasionally discuss potential negative effects of psychotherapy
(e.g., on an as-needed basis) during the informed consent process, they may not be aware
of the extent to which this phenomenon exists. Common finding among psychotherapy
outcome studies reveal negative responders tend to be embedded in the outcome variance
or appear simply not to be reported (Mohr, 1995; Dishion, McCord, & Poulin, 1999).
The field of psychotherapy has tended to avoid examining negative outcomes by not
reporting them, which Mohr (1995) suggest is problematic and limits the overall potential
for the psychological profession. As a result, the lack of accurate information from
research, related to negative effects of psychotherapy, may contribute to psychologists’
currently held attitudes and beliefs. Research findings suggest that there appears to be a
similarity in the reported ethics and belief systems of psychotherapists and in their
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subsequent practices (Somberg, Stone, & Claiborn, 1993; Pope, Tabachnick, & KeithSpiegel, 1987). Therefore, it is important to understand licensed psychologists’ current
attitudes and practices regarding the informed consent process related to addressing risk
of potential negative treatment effects of psychotherapy.
Purpose of the Study
This study examined the general attitudes and practices of licensed psychologists
relative to informing clients, during the informed consent process, of potentially negative
effects of psychotherapy. In order to better understand the current practices of addressing
risk during informed consent, attention needs to be given to attitudes. Although
psychologists believe in the general application of informed consent (Somberg, Stone &
Clairborn, 1993), little information is available about specific informed consent issues
and practices. For example, attitudes about the impact of consent procedures may impact
a psychotherapist’s decision. Attitudes related to addressing risk of negative treatment
effects that are thought; to some degree to affect the therapeutic relationship negatively
might change the implementation of informed consent practice (MacDevitt & Acker,
1990). Although there is no evidence, empirically, to support negative expectation
(Handelsman, 1990) for informed consent practices, concerns may be present for
practicing clinicians.
Information obtained from this survey study could be used to improve clinical
guidelines and standards of disclosure for licensed practicing psychologists relating to the
process of informed consent. Demographic variables (e.g., age, gender, ethnicity, degree,
primary theoretical therapeutic orientation, practice setting, years working as a licensed
psychologist, primary population treated, primary therapeutic modality, American Board
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of Professional Psychology (ABPP) certification, and post-doctoral training on ethics and
informed consent) were examined in relation to licensed psychologists’ attitudes and
practices related to addressing potentially negative effects of psychotherapy; in addition
to this, the relationship between attitudes and practices was studied. The method
included a survey questionnaire which was developed by the researcher (see Appendix
B). The sample consisted of 161 currently licensed doctoral level psychologists from a
nationwide population. Information gathered by this study contributes to the sparse
literature related to psychologists’ attitudes and practices toward addressing negative
effects of psychotherapy during the informed consent process. This study aids
psychological, as well as other mental health professionals, gain a more thorough
understanding of how the psychological profession implements the APA's Code of Ethics
into psychotherapy practice and the process of informed consent.
This study intended to answer several general research questions:
1) Do licensed psychologists address, as part of a conversation of risks, potentially
negative effects of psychotherapy during the informed consent process?
2) What are licensed psychologists’ general attitudes and practices toward
addressing risk of negative effects of psychotherapy during the informed consent
process?
3) What are licensed psychologists’ general attitudes toward APA’s ethical practices
and implementation of informed consent procedures?
4) What is the relationship between number of years of formal training as a licensed
psychologist and subsequent attitudes and practices toward addressing risk related
to negative effects of psychotherapy during the process of informed consent?
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5) What is the relationship between licensed psychologists’ theoretical therapeutic
orientations and attitudes and practices toward addressing negative effects of
psychotherapy during informed consent?
6) What is the relationship between licensed psychologists’ attitudes and practices
toward therapeutic privilege related to addressing risk of negative effects of
psychotherapy during the process of informed consent?
7) What are licensed psychologists’ general attitudes and practices toward a
discussion of alternative treatment and/or procedures during the informed consent
process?
Relevance to Cognitive Behavior Therapy
The application of ethical practices to psychotherapy is complex and there is
minimal research to illustrate how psychologists generally implement informed consent.
Although many professional psychologists view the informed consent process as a means
of implementing ethical responsibility to their clients (e.g., Handelsman & Galvin, 1988;
Hare-Mustin, Maracek, Kaplan, & Liss-Levinson, 1979; Noll & Haugan, 1985), there is
limited explicit recognition or even limited discussion in the literature outlining the need
to address risks including potentially negative effects of psychotherapy. Ethical
responsibility and the requirement of informed consent are derived from the principle of
respect for individual autonomy (Faden & Beauchamp, 1986; Kitchener, 1984).
According to this principle, an individual has the right to act as an informed free agent
when making a decision (Kitchener, 1984). In order to do so, however, the individual
needs information that is relevant to making his or her decision. Informed consent helps
maintain an individual’s autonomy by ensuring that the individual has received relevant
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information, regardless of whether or not he or she intends to use the newly acquired
knowledge (Handelsman & Galvin, 1988).
Some therapeutic orientations may lend themselves, in a greater degree, toward
encouraging autonomy in their clients. Client autonomy, for example, is a fundamental
aspect of Cognitive-Behavioral Therapy (CBT). In their study, Somberg et al. (1993)
revealed “therapists of a Cognitive-Behavioral orientation indicated they inform clients
more often and consider the issues more important” than therapists from other therapeutic
orientations (p. 153). CBT includes a collaborative emphasis with active participation
and a team-work approach, in which client and therapist decide together what to do in
session and how often to meet (Beck, 1995). The “shared decision making” approach,
according to Knapp and VandeCreek (2006), reflects those “mutually agreed upon goals
and intervention strategies” as part of the therapist-client collaboration during informed
consent (p. 99). With such a strong emphasis on the client’s taking an active role in
treatment, it seems that psychologists whose primary orientation is CBT would be more
likely to encourage client participation and be more likely to inform clients of potential
risks during the process of informed consent.
Overview of Literature Review
Presented next is an overview of informed consent, including the various
historical, ethical, religious, and legal influences that have shaped its process. Following
that, issues related to the application of informed consent, including the risks and benefits
of negative treatment effects will be highlighted and discussed. Careful considerations
relative to addressing negative treatment effects as a result of psychotherapy are
explored. After that, the methodology used for the study and the results of the study are
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presented and discussed. A discussion of the conclusions will be presented and explored.
Finally, limitations of the survey study and directions for future research are addressed.
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Chapter Two: Review of the Literature
Defining Important Terms
Psychotherapy. A classic definition of “psychotherapy” originally defined by
Stoudemire (1998) and later articulated by Beahrs and Gutheil (2001), include the “use of
interpersonal influence skills and psychological techniques by trained professionals
toward the goal of relieving the signs and symptoms of psychiatric disorder” (p. 4).
Psychotherapy is defined as a “procedure,” similar to that of a medical procedure (Beahrs
& Gutheil, 2001). Research concludes that psychotherapy be considered a well-proven,
well-researched and effective tool, used to relieve both symptomatic psychic distress and
other medical illnesses (Bloom, 1992; Sperry, Brill, Howard, & Grissom, 1996; Gabbard,
Lazar, Hornberger, & Spiegel, 1997; Stevenson & Meares, 1992). Despite its widespread
use, psychotherapeutic treatment is ambiguous and adds to the complexity of defining
potentially negative effects in psychotherapy. The manner of delivery of a
psychotherapeutic treatment can be both harmful and helpful and can be applied in a
variety of ways, depending on the skill level of the psychologist and the context of the
intervention. Scientific texts, the legal system, and third-party payers have impacted the
practice of psychotherapy and created significant legal implementations, similar to those
found within the medical profession (Beahrs & Gutheil, 2001). One of the most
important of these constraints is the duty of mental health professionals to provide clients
with informed consent.
Informed consent. An overarching definition of “informed consent” according
to Berg, Applelbaum, Lidz, and Parker (2001) includes:
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Legal rules that prescribe behaviors for physicians and other health care
professionals in their interactions with patients and provide penalties, under given
circumstances, if physicians deviate from those expectations; to an ethical
doctrine, rooted in our society's cherished value of autonomy, that promotes
patients' right of self-determination regarding medical treatment; and to an
interpersonal process whereby these parties interact with each other to select an
appropriate course of medical care (p. 3).
Because of the complexity of the term, for the purpose of this proposal, “informed
consent” may be thought of, according to Simon (1992) and explicitly described by
Beahrs & Gutheil (2001) as “a process of sharing information with patients that is
essential to their ability to make rational choices [for psychotherapy] among multiple
options in their perceived best interest” (p. 4). As a prerequisite to engaging potential
clients in psychotherapy, the Ethics Code (2002, Section 10) mandates a necessary
informed consent discussion. The ideal format according to Jensen, McNamara, and
Gustafson (1991) for informed consent for psychotherapy must include a discussion
between therapist and client of goals, methods, concomitant benefits and risks of
psychotherapy, as well as possible alternatives to the proposed treatment.
Negative treatment effects. There are issues in definition about how to label
psychotherapy decline. Originally defined by Strupp and Hadley (1976), the term
“negative treatment effects” applied to “patients getting worse as a function of the
therapeutic influence” (e.g., iatrogenic effects) as opposed to the term “negative
outcome” which pertained to a decline in functioning regardless of the original cause(s)
(e.g., deterioration effects) (Mays & Franks, 1985, p. 20). Despite the researchers’
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classic definition, the term “negative effect” appears to be used interchangeably with
“negative treatment effects” within the research literature. For example, Mays and
Franks (1985) suggested “negative effect” or “negative outcome” should be applied to
patients who got worse, even when there appeared to be no evidence that individuals who
became worse was a direct consequence of psychotherapy. In their research, Dies and
Teleska (1985), use “negative outcome” to imply that a patient was becoming worse in
his or her overall functioning or symptomology, as a result of treatment. Bergin (1963)
used the term “deterioration effects” in his research to describe individuals who decline
in psychotherapy, when there appeared to be greater variability in the experimental group
than in the control group on criterion measures in psychotherapy. In his review of
psychotherapy research, Bergin (1963) noted there were a consistently larger proportion
of individuals in the experimental groups whose symptoms improved and got worse, than
in the comparison groups. The judgment of causality, according to Lieberman et al.
(1973), is based on the finding that an individual has “deteriorated in major adult role
functioning” (as cited in Roback, 2000, p. 115). Because of the variability in terminology
among researchers and clinicians, it is difficult, if not almost impossible, to operationally
define negative effects of psychotherapy.
The lack of consensus in existing literature related to what constitutes negative
effects of psychotherapy reflects the conceptual complexities in this area. One classic
definition states that negative effects occur “when there is no meaningful positive change
in a client due to some aspect of the treatment process” (Nolan, Strassel, Roback, &
Binder, 2004, p. 311). The most extreme negative effect is related to “client deterioration
in functioning that is attributed to the course of therapy” (Nolan et al., 2004, p. 311).
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Lilienfeld (2007) utilizes the term “psychological harm” as including “not only
deterioration but also a decelerated rate of improvement that is a consequence of
psychotherapy” or something that is attributable to the direct effects of psychotherapy (p.
57). Mohr (1995) describes both terms “potential negative effects for treatment” and
“potential deterioration” interchangeably in his research (p. 189). The five indicators for
“potential deterioration,” as a result of interaction between therapeutic techniques,
psychotherapists, and clients include, “(a) the role of anticipation of emotional pain and
therapeutically induced arousal, (b) client suspiciousness toward the therapist and
therapist empathy, (c) level of interpersonal functioning and the focus of treatment, (d)
diagnosis and treatment modality, and (e) relaxation therapy and clients’ need for
control” (Mohr, 1995, p. 187).
Negative treatment effect detection during the course of psychotherapy is
similarly complex. Clinical experience is often valued among psychologists as a method
to assess treatment progression, including ways to proceed with the course of
psychotherapy (Stewart and Chambless, 2007). Research has demonstrated, through the
use of empirical and actuarial models, correctly identifying risk for treatment failure are
reliably superior to the use of clinical judgment (Kadden, Cooney, Getter, & Litt, 1989;
Lutz, et al., 2006; Shulte, Kunzel, Pepping, & Shulte-Bahrenberg, 1992; Stewart and
Chambless, 2007).
Because psychotherapy outcome is multidetermined, the question arises about
which factors may potentially have the strongest influence on client outcome. Results
from research conclude client characteristics “are the most powerful determinants of
outcome” (Sachs, 1983; Gomes-Schwartz, 1977). However, it has also been noted by
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Luborsky et al. (1980) that “patient characteristics only account for a small proportion of
the variance” (as cited in Sachs, 1983, p. 558). According to client-centered theorists,
therapist factors are also considered important to overall psychotherapy outcome (Sachs,
1983). Although specific techniques do not seem to have a “differential effect on
outcome”, personal characteristics of both the client and therapist appear to be the
“strongest determinants of outcome” (Sachs, 1983, p. 558). In a research study on
characteristics of the therapeutic process (among psychodynamic and experiential
therapy), and its relationship to negative outcome, Sachs (1983) revealed that factors
shown to be highly related to client outcome were associated with the quality (or lack of
quality) of a therapeutic technique.
From the time Sigmund Freud introduced the term “countertransference” (in
1910), there have been insufficient cases in the research literature on “negative
therapeutic reaction to describe patients who apparently fail to benefit from
psychotherapy or get worse” (Mays & Franks, 1985, p. 21). Although the psychoanalytic
literature considers lack of successful treatment regarding both clients (e.g., Freud,
1937/1964) and therapists being primarily related to “countertransference” (e.g., Gorkin,
1987), other examples of failure cases are rare (Rogers, 1954; Stricker, 1995). Strupp et
al. (1977) conducted one of the most comprehensive reviews of negative effects of
psychotherapy among experts in the field (researchers, clinicians, and theoreticians) from
various theoretical orientations. Nearly every one of the 70 prominent psychotherapists
who responded to the survey by Strupp et al. (1977) agreed that psychotherapeutic
negative effects were problematic and concluded “a worsening of a patient's condition
attributable to his having undergone psychotherapy” (p. 91) was what these negative
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effects entailed. Strupp et al. (1977) discuss two kinds of negative effects as a result of
psychotherapy, “those generally harmful to patient, and those harmful to the attainment
of the goals of therapy which may or may not include harm to the patient” (as cited in
Mays & Franks, 1985, p. 21). Strupp et al. (1977) reveal that negative effects are
associated with a variety of problems related to inaccurate assessment, patient or therapist
qualities within the therapeutic relationship, and among techniques or treatment
approaches. It appears challenging in psychotherapy research to be able to separate
iatrogenic effects from deterioration effects with significant confidence because there
could be other factors within the psychotherapeutic process to account for the negative or
adverse outcomes (Roback, 2000).
Psychotherapy Failure versus Treatment That May Cause Harm
Therapeutic failure (no clinical improvement). Research is limited regarding
decision practice to discontinue psychotherapy when clients fail to make progress. The
Ethics Code (2002) dictates that psychologists strive for beneficence and strive to do no
harm; however, when psychologists continue to treat clients who appear to gain no
benefit from psychotherapy, Stewart and Chambless (2008) note, “This practice in itself
can be harmful” (p. 176). In order to achieve clinically significant improvement, Hansen,
Lambert, and Forman (2002) suggest treatment duration lasting from 13 to 18 sessions.
In a recent study, Stewart and Chambless (2008) surveyed psychologists in independent
practice (N=591) regarding treatment failures. Psychologists reported that clients
attended psychotherapy for a “median of 12 times before concluding no progress was
being made” (p. 179). Specifically, 36 percent of psychologists reported treating clients
who were not improving for longer than 19 sessions, and 10 percent reported treating
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those clients for longer than 30 sessions before “concluding failure” (p. 180).
Psychologists rated “colleague consultation and clinical experience” as primary methods
for termination decision, rather than empirical research (p. 179). These researchers
reported that psychologists’ theoretical orientation impacted the definition of failure and
subsequent treatment decision. Specifically, psychologists from a psychodynamic
orientation tended to treat clients “significantly longer” than those from cognitivebehavioral and/or eclectic orientations (p. 176). Cognitive-behavioral and other eclectic
clinicians tended to use “treatment materials informed by psychotherapy outcome
research and refer patients to other clinicians” more often, than those from the
psychoanalytic approach (p. 176). In light of evidence-based practice, the tendency to
rely on clinical experience alone rather than on empirical research to inform practice is
inconsistent with current trends in outcome literature. Therapeutic failure, according to
Stewart and Chambless (2008), has both an immediate effect, leaving clients in an
“unimproved or even deteriorating state” and the potential to change clients’ perceptions
of “psychotherapy and make them subsequently less likely to pursue psychotherapeutic
treatment” for their difficulties (p. 180). There is a clear distinction between no clinical
improvement and psychotherapy failure and a client’s becoming worse, as a result of
harmful or negative treatment effects.
Treatment that may cause harm. There are methodological issues that
complicate defining psychological harm operationally. Research is limited, to date, that
outlines how mental health professionals define client improvement or worsening as a
result of engaging in psychotherapy. Clients’ overall symptomology may improve over
the course of treatment; however, use of an alternative (more effective) treatment may
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have speeded up the process. It could be argued that psychotherapy, in this regard, could
be thought of as harmful because it took the client longer for his or her symptoms to
dissipate. It is difficult to know whether or not deterioration effects may have occurred
without the intervention, or perhaps participation in treatment may have slowed down the
deterioration process. The potential of psychotherapy to cause harm can occur as a result
of the psychotherapeutic treatment or decisions made about the treatment (Lilienfeld,
2007). Negative effects that result from harmful treatment are thought to have a causal
effect because the outcomes produced are worse than if there were no treatment. There
are numerous instances of known psychotherapeutic treatments and techniques that have
the potential to cause harm, including: critical incident stress debriefing, facilitated
communication, recovered-memory techniques, boot camps for conduct disorder,
attachment therapy, dissociative identity disorder-oriented psychotherapy, grief
counseling for normal bereavement and expressive-experiential psychotherapies
(Lilienfeld, 2007). Potentially problematic psychological treatments, Lilienfeld (2007)
notes, that have a tendency to produce both positive and negative effects, should be used
with particular caution. Although the prevalence of questionable psychotherapy practices
is presently unknown, Lilienfeld (2007) indicates that research-oriented mental health
professionals may underestimate how often and when they are utilized.
There is a current lack of consensus within the psychological field regarding
harmful treatment detection and subsequent practices. For the purpose of this study, it is
noteworthy to make a distinction in definition because failure to provide appropriate
treatment that could have improved a client’s symptomology is different from providing
treatments that cause harm. Related to this are psychological treatments and techniques
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that are considered unhelpful (e.g., a client in treatment for depression who commits
suicide). The distinction lies between clients experiencing negative effects as a result of
having a psychological disorder, and negative treatment effects as a result of engaging in
potentially harmful treatment. Although psychological disorders can cause a myriad of
harmful negative effects, this study’s focus will be on harm that results from
psychotherapeutic treatment application, not on harm embedded in the psychological
disorder itself. Whittington et al. (2004) assert that psychotherapeutic treatment has the
potential to impact a disorder negatively and adversely impact other domains. For
example, the use of selective serotonin reuptake inhibitors (SSRI’s), as antidepressant
medications with adolescents, has been associated both with improvement in depressive
symptoms and with a potential to increase risk for suicide (ideation and attempt)
(Whittington et al., 2004). Data from empirically-based research suggest exposure
therapy is thought to lead to increased levels of distress during implementation (an issue
of concern for those who use this method of treatment with post-traumatic stress
disorder) (Foa, Zoellner, Feeny, Hembree, & Alvarez-Conrad, 2002). Nishith, Resick,
and Griffin (2002) report a small minority of clients (who engaged in exposure therapy
treatment) displayed reliable increases in general anxiety, and others experienced an
exacerbation of post-traumatic stress disorder symptoms. Similarly, Neimeyer (2002)
suggested clinical concern regarding the use of grief therapy treatment and its potential to
interfere with the normal process of recovery from loss, over time. Addler, Craske, and
Barlow (1987) suggested that the phenomenon of harmful effects may occur if such
effects may be moderated by client characteristics. Although relaxation techniques are
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beneficial to the majority of clients, they can also induce panic attacks among a small
minority of individuals who engage in this form of psychotherapy treatment.
There are potential problems in not having a consensus of definition both in
research and in practice. An operational definition of potentially negative treatment
effects (including treatment that does not work and may cause harm) from psychotherapy
would aid in understanding the occurrence of these effects, including how they impact the
client population. It would also be beneficial to define these problematic effects so that
practicing psychologists can address and articulate them during the informed consent
process. A lack of terminology consensus suggests that even experts struggle to discern
trends in this area of psychotherapy research. It appears unrealistic to expect
psychologist practitioners to draw consistent conclusions about negative effects of
psychotherapy from literature that does not necessarily lend itself to consistent
conclusions.
Informed Consent Underpinning
Informed consent is the process by which clients are informed of their rights
regarding psychotherapeutic treatment, as well as the benefits and risks of treatment. The
foundation and justification of informed consent derive from various lines of reasoning
including philosophy, religion, and the law.
Philosophical support. The origin of informed consent, according to Levine
(1995), is derived from the ancient Hippocratic directive “to help, or at least to do no
harm” – in which the benefit for seeking information for the client “provides a
mechanism for ascertaining what the patient would consider a benefit” (as cited in
Emanuel, Crouch, Arras, Moreno, & Grady, 2003, p. 197). Allowing an individual to
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decide what is beneficial “is consistent with the perspective affirmed in U.S. public
policy that competent persons are generally the best protectors of their own well-being”
(as cited in Emanuel et al., 2003, p. 197). However, ensuring adequate consent when
potentially negative effects are of concern, appear more complex than acquiring consent
when an individual might think that the effects would be beneficial. The requirements
for informed consent derive from the principle “respect for persons”, which according to
Levine (1995) include two basic “ethical convictions” outlined by the U.S. National
Commission for the Protection of Human Subjects of Biomedical Research (hereinafter,
NCPHSBR), which ensure individuals be treated as “autonomous agents” with particular
emphasis for protection of those individuals “with diminished autonomy... are entitled to
such protection” (as cited in Emanuel et al., 2003, p. 197).
Religious support. The Judaeo-Christian tradition is another origin for the
requirement of seeking consent. Levine (1995) notes the requirement for consent “is
grounded explicitly in the notion of covenant”, and that seeking adequate consent “is an
affirmation of the basic faithfulness of care required by the fundamental covenantal
nature of human existence” (as cited in Emanuel et al., 2003, p. 197). The notion that
human life is a “gift from God and is of infinite and immeasurable worth (the 'sanctity of
life')” reflects the religious understanding of how individuals should act toward each
other “with respect and not interfere in each other's lives without consent” (as cited in
Emanuel et al., 2003, p. 197).
Legal support. Informed consent in the legal context was clarified in by a 1914
New York Supreme Court decision. As part of a response to a medical malpractice suit,
Justice Benjamin Cardozo asserted “every human being of adult years and sound mind

INFORMED CONSENT IN PSYCHOTHERAPY

20

has a right to determine what shall be done with his own body” (Schloendorff v. Society
of NY Hospital, 1914). It is from this principle of “bodily integrity” Levine (1995) notes
that the modern idea of informed consent grew within the medical profession. An
individual has the right to chose what is done to him or her, and no physician has the
right to touch a patient without the person’s explicit consent. Failure to obtain adequate
informed consent, according to Levine (1995), could result in a charge of battery or
negligence for which the plaintiff may claim damages and receive financial compensation
(Emanuel et al., 2003). The main purpose of the informed consent requirement,
according to Levine (1995), is not necessarily to lessen the occurrence of risk or harm
resulting from treatment, but to give an individual the option to chose whether or not to
participate (Emanuel et al., 2003).
Although the legal basis for an informed consent requirement arose as a result of
medical practice litigation, Levine (1995) asserts that there is currently no case law
related to “legal standards for consent to research, as distinguished from practice” (as
cited in Emanuel et al., 2003, p. 197). If informed consent was not adequately obtained,
Levine (1995) notes, it “was traditionally considered as a battery action [where] the law
of battery makes it wrong, a priori to touch, treat, or do research upon a person without
the persons consent” (as cited in Emanuel et al., 2003, p. 198). In recent years, however,
malpractice litigation tends to view obtaining insufficient informed consent as “as
negligence rather than battery actions” (as cited in Emanuel et al., 2003, p. 198).
Similarly, in order to “bring a negligence action, a patient/subject must prove that the
physician had a duty toward the patient; that the duty was breached; and that the damage
was caused by the breach” (as cited in Emanuel et al., 2003, p. 198). According to the
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law, if any information is withheld from the potential patients/clients that would have
been pertinent to their decision to give informed consent, it is considered invalid under
both the battery and negligence doctrines (Emanuel et al., 2003).
Informed Consent Historical Factors
The concept of informed consent has distant roots in medical ethical principles of
beneficence, doing no harm, and helping patients (Faden & Beauchamp, 1986; Chadwick
& Mann, 1978). Obtaining patient/client involvement in treatment decisions is somewhat
contemporary and has become a more stringent requirement in recent years (Walker,
Logan, Clark, & Leukefeld, 2005; Manning & Gaul, 1997). What once was considered
good patient overall care, when physicians tended to act on their own authority without
informing patients about important treatment decisions, has dramatically changed (Katz,
1999). The previous paternalistic viewpoint tended to focus on whether or not patients
would be able to understand or comprehend the information presented to them, which
subsequently led to inadequate information obtained about treatment (Katz, 1999). The
first evidence of informed consent as a major issue in American medicine was in the late
1950's and early 1960's (Faden & Beauchamp, 1986). Although general medicine began
incorporating informed consent, psychotherapy avoided the widespread use of informed
consent until the Osherof f v. Chestnut Lodge legal case during the 1980's, which raised
serious questions about the duty of providers to explain fully, the diagnoses and
alternative treatments (i.e., risks and benefits) to clients (Beahrs & Gutheil, 2001;
Klerman, 1990). Subsequently, client's rights started to become a priority in obtaining
the most effective and efficacious psychological treatment (Klerman, 1990). Although
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Osheroff v. Chestnut Lodge case never reached final court adjudication, it started a dialog
between mental health and legal professionals (Klerman, 1990).
The last century witnessed multiple cases of unethical and uninformed treatment
of human participants under the guise of research. The most notable of these infamous
research cases included the Tuskegee Syphilis, Willowbrook, Tearoom Trade, Jewish
Chronic Disease hospital, and the Milgram study. In order to understand the natural
progression and treatment of syphilis, the United States Public Health Service initiated
the Tuskegee Syphilis study in 1932, on 399 lower socioeconomic African-American
males who had syphilis, and 201 controls who did not, from Macon County, Alabama
(Centers for Disease Control and Prevention [CDC], 2008; Rothman, 1982). No
informed consent of any kind was utilized; rather, subjects were coerced into
participation through a variety of unethical means. Although penicillin was an accepted
and effective form of treatment in 1943, its knowledge and usage was deliberately
withheld from study subjects; neither were participants allowed to obtain any other
treatment for syphilis (CDC, 2008; Rothman, 1982). Throughout the forty years of the
study, 100 subjects died as a direct result of untreated, late stage neurosyphilis (CDC,
2008; Rothman, 1982). Although the study was published in several medical journals, it
was never formally, ethically questioned until 1972, when the press reported on it; the
result was public outrage. Similarly, the Willowbrook State Hospital study conducted in
Staten Island, New York, (from 1963 to 1966), involved a group of children diagnosed
with mental retardation who were deliberately infected with the hepatitis virus (Rothman,
1982). Of primary concern was the coercive manner in which the parents were
convinced to enroll their children with mental retardation in the study; it was done in
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exchange for hospital admission and deliberate infection (Rothman, 1982). In the
Tearoom Trade study (1960), a researcher who wanted to study the motivations of men
who had public sex in restrooms, posed as a friend by acting as a “lookout” (Warwick,
1973). The researcher then identified the participants by tracking them down by their car
license plates and posing as a “health-care worker” in order to visit these men at home
(Warwick, 1973). In the Jewish Chronic Disease Hospital study in New York, (1963),
chronically ill, cancer-free patients were injected with live human cancer cells (Galietta
& Stanley, 2007). Physicians did not inform their patients (in an effort not to scare them)
because of the physicians’ beliefs that the cancer cells would be rejected (Galietta &
Stanley, 2007). Last, in the classic yet controversial behavioral study on obedience,
Milgram deceived subjects by misinforming them about the true purpose of the
experiment, by making them believe they were administering real electric shocks to real
subjects (Milgram, 1974). The study raised serious ethical questions about the use of
human subjects in psychology experiments. The lack of informed consent among these
studies and other infamous research cases emphasized the need to protect the rights and
welfare of human participants in research.
Informed consent in treatment originally developed from the notion of the need
for increased protection applied to research with human participants. In fact, the
Nuremberg Code, Declaration of Helsinki, and the Belmont Report issued by the
NCPHSBR, have declared definitive standards for obtaining informed consent for human
participant research, prior to beginning medical experiments or for treatments that might
result in harmful or negative treatment effects.
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The 1947 Nuremberg Code (Permissibly Medical Experiments, n.d.) arose out of
a response to the post-Second World War trials of Nazi doctors who committed heinous
crimes against humanity on concentration camp prisoners in the name of biomedical trials
and experiments for research. The first sentence of the Nuremberg Code asserts
“voluntary consent of the human subject is absolutely essential”, which highlights the
importance of the consent requirement in research involving human participants
(National Institutes of Health [NIH], 2008). In the case of United States v. Karl Brandt et
al., the Nuremberg Military Tribunal's decision includes what is now called the
Nuremberg Code (1947) (Permissible Medical Experiments, n.d). A ten point statement
outlining permissible medical research on human subjects is justified only if results are a
benefit to society at large, and if it is carried out in accordance with basic principles that
maintain allegiance to moral, ethical and legal standards (NIH, 2008, n.p.). Some of
those principles include ensuring the rights of human participants in research. The most
notable of these directives for human experimentation, according to the Office of
Scientific Research, National Institutes of Mental Health (NIMH, 2008) include:
(a) informed, voluntary consent, (b) research must be purposeful and necessary
for the benefit of society, (c) research must be based on animal studies or other
rational justification, (d) avoidance and protection from injury, and unnecessary
physical and mental suffering, (e) risks to the subject shall not be greater than the
humanitarian importance of the problem, (f) investigators must be scientifically
qualified, and (g) subject may terminate the experiment at any time (n.p.).
The Nuremberg Code's (1947) requirement for individual consent to participate in
research, include four factors outlined by Levine (1995); these are: the ability to exercise
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free choice, possess the legal capacity, have sufficient comprehension to make a decision,
and have sufficient knowledge to decide (Emanuel et al., 2003). If any of these four
conditions are compromised, ethical acceptability of consent itself is imperiled. Levine
(1995) argues that the Nuremberg Code's (1947) usage of the term “voluntary consent”
rather than “informed consent,” indicate primary focus on the notion of “freedom of
choice” - rather than on “quality or quantity of information transmitted” (as cited in
Emanuel et al., 2003, p. 199). The “free power of choice” objective includes “any
element of force, fraud, deceit, duress, overreaching, or other ulterior forms of constrain
or coercion” must not be present in obtaining consent (Emanuel et al., 2003, p. 199).
The knowledge or information component of the consent process is what makes it
informed. There is much debate over the kind of information potential that research
participants need in order for them to make an informed decision. Katz reveals that
potential participants “still may fail to understand when a proposed intervention poses
uncertain and perhaps significant risks or offers no prospect of therapeutic benefit to
them as individual patients” (as cited in Siminoff, 2003, p. 1). Research literature reveals
the fact that most research participants have significant gaps in the ability to recall and
understand information presented during informed consent; information tends to be
relayed in a manner that is difficult to understand, and information from consent forms
are frequently hard to read and absorb (Kent, 1996; Tuckett & Williams, 1984; Meade &
Howser, 1992; Wu & Perlman, 1988). Siminoff (2003) indicates that patients, “are
limited in their ability to assimilate very large amounts of new information quickly”, in
order to make an informed decision (p. 2). In a large NIMH (1997) study conducted in
various locations (large hospitals and outpatient offices) on informed consent, researchers
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examined the needs of vulnerable populations (individuals with cognitive impairment and
the critically ill), including the quality of consent (forms), the process of obtaining
consent, decisions made and recalled, anxiety, proxy decision-makers and other
psychosocial outcomes (Siminoff, 2003). Several findings revealed that the importance
of the clinical setting and the context of the illness are important factors for informed
consent (Siminoff, 2003). Interestingly, individuals whose surrogates made decisions for
them, made choices significantly different from the participants themselves; this resulted
in a greater “thresholds for risk” when decisions were made by another person (Siminoff,
2003, p. 2). This study underscores the importance of the need to have informed consent
research, based on theories of communication and decision-making (Siminoff, 2003).
The Nuremberg Code's (1947) requirement to consent, as outlined by Levine
(1995) include both a “legal capacity to consent” (often referred to as “competence”) and
“sufficient understanding” in order to reach an “enlightened decision” (as cited in
Emanuel et al., 2003, p. 199). Levine (1995) argues that within the definitions of
competence are elements of comprehension related to an individual’s ability to “evaluate
relevant information, understand the consequences of action, and to reach a decision for
rational reasons” (as cited in Emanuel et al., 2003, p. 199). An assessment for
incompetence, according to Levine (1995) includes four basic themes:
(1) Reasonable outcome of choice. This is highly paternalistic standard because
the individual's right to self-determination is respected only if he or she makes the
“right” choice – that is, one that accords with what the competency reviewer
either considers reasonable or presumes a reasonable person might make; (2)
Factual comprehension. The individual is required to understand, or at least be
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able to understand, the information divulged during the consent negotiation; (3)
Choice based on rational reasons. Individuals must demonstrate a capacity for
rational manipulation of information. They may, for example, be required to
show that they not only understand the risks and benefits but also have weighted
them in relation to their personal situations; (4) Appreciation for the nature of the
situation. Individuals must demonstrate not only comprehension of the informed
consent information but also the ability to use the information in a rational
manner. Furthermore, they must appreciate the fact that they are being invited to
become research subjects and what that implies (as cited in Emanuel et al., 2003,
p. 200).
The U.S. Presidential Commission for the Study of Ethical Problems in Medicine
and Biomedical Research (2008) (hereinafter, U.S. President's Commission) outlines the
requirements for individual capacity to make a decision, “(1) possession of a set of values
and goals; (2) the ability to communicate and understand information; and (3) the ability
to reason and deliberate about one's choices” (n.p.). Although the U.S. President
Commission (2008) endorsed an individual's capacity for assessment, it recommends a
balance between well-being and self-determination related to potential consequences of a
patient's decision. Specifically, when the consequences for well-being are substantial,
there is a greater need to be certain that the patient possesses the necessary level of
capacity.
Research on informed consent is inconsistently related to what constitutes
appropriate assessment for competence. According to Plaut (1989), the issue of
competence related to an individual's ability to give truly informed consent, creates many
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ethical dilemmas. Although there are no obvious difficulties at either end of the
spectrum, because “the fully conscious, rational patient under no duress can of course
give informed consent; the unconscious or totally confused and disoriented patient
cannot,” Plaut (1989) argues that there exists “a large gray area in between” (p. 436).
Interestingly, there appear to be no specific legal cases or precedents to guide research.
Although the traditional standards for guardianship and ability to stand trial exist, they do
not seem applicable or appropriate to informed consent (Plaut, 1989). Although a
determination of incompetence appears relevant for informed consent, it tends to impact
very few areas of the ability to make decisions. For example, Levine (1995) argues that
an individual who is legally competent may not be functionally incompetent, just as
someone who is legally incompetent can be thought functionally competent (Emanuel et
al., 2003). Even though lacking legal capacity or comprehension is prohibited for
participant research by the Nuremberg Code (1947), this is not the case in all Codes.
Most Codes and guidelines discuss obtaining permission for consent from the legal
guardians of those individuals lacking the adequate capacity to give consent.
Adequate disclosure to the patient, according to the Nuremberg Code (1947),
require as Levine (1995) asserts, the potential participant be told “the nature, duration,
purpose of the experiment; the methods and means by which is conducted, all
conveniences and hazards reasonably to be expected; and the effects upon his health or
person which may possibly come” (as cited in Emanuel et al., 2003, p. 200). The U.S.
Code of Federal Regulations (hereinafter, CFR) have expanded on these codes and
regulations to include:
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(1) a statement of the purpose of research and a description of its procedures; (2) a
description of foreseeable risks and discomforts; (3) a description of benefits; (4)
disclosure of appropriate alternatives, if any; (5) a statement of the extent of
confidentiality; (6) an explanation of the availability of medical treatment for
injury and compensation for disability; (7) an explanation of whom to contact for
answers to questions; and (8) a statement that participation is voluntary and that
neither refusal to participate nor withdraw at any time will result in a loss of
benefits to which the subjects is otherwise entitled (CFR, 2008, n.p.).
There appears to be no universal agreement on standards for disclosure of information
and/or what it takes for a person to have sufficient knowledge to give informed consent
(Emanuel et al., 2003). Levine (1995) argues that those who “agree on the need for
disclosure of information in a particular category – the risks for example, often disagree
on the nature of the information that must be made known” (as cited in Emanuel et al.,
2003, p. 201). Levine (1995) suggests, for example, that it is unclear, in the Nuremberg
Code (1947) where it describes “explication of hazards 'reasonably to be expected,'”
whether this means there could be a “very slight chance of substantial harm, or a
substantial chance of a very slight harm” (as cited in Emanuel et al., 2003, p. 201).
Similarly, within the legal context, neither the “quality nor the probability of risks to be
divulged has been clearly determined” (Emanuel et al., 2003, p. 201).
The Nuremberg Code (1947) failed to produce a broader “legal doctrine
protecting individuals against harm induced by scientific practices at large, including not
only human beings as subjects of medical experiments but also as consumers and
beneficiaries of science's outcomes” (Thieren & Mauron, 2007, p. 1). The Nuremberg
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Code (1947) is often thought of as the predecessor of later codes which intend to assure
an ethical manner for human participant research. Because the Nuremberg Code (1947)
does not address research in patients with illnesses, the Declaration of Helsinki (1964)
has been thought to be more preferable ethical guide for patient/client experimentation in
research.
The Declaration of Helsinki's (1964) original document, much like the Nuremberg
Code (1947) was written in response to the unethical medical experiments of the Nazi
physicians during the Second World War. While the publication has been revised several
times by the World Medical Association (WMA), the latest version asserts that "the wellbeing of the human subject should take precedence over the interest of science and
society" (WMA, 2000). Physicians are expected to both act in their patients’ best interest
and to view an individual's heath and overall well-being as priority. The main principles
of this document are incorporated in a great number of national research regulations and
guidelines. The most recently revised declaration asserts the following regarding
informed consent:
In the treatment of a patient, where proven prophylactic, diagnostic and
therapeutic methods do not exist or have been ineffective, the physician, with
informed consent from the patient, must be free to use unproven or new
prophylactic, diagnostic and therapeutic measures, if in the physician's judgment
it offers hope of saving life, re-establishing health or alleviating suffering. Where
possible, these measures should be made the object of research, designed to
evaluate their safety and efficacy. In all cases, new information should be
recorded and, where appropriate, published (WMA, 2000, n.p.).
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In 1947 the National Research Act was passed by the United States Congress.
Although both international codes, the Nuremberg Code (1947) and the Declaration of
Helsinki (1964) were generally used as guides for researchers conducting
experimentation with participants, the United States government continued to sponsor
unethical human experimentation (Zimmerman, 1997). The NCPHSBR, created by the
National Research Act (1947), included professionals from ethics, science, and the law,
who made recommendations to the Department of Health and Human Services
(hereinafter, DHHS). One of the Commission's statements was The Belmont Report:
Ethical Principles and Guidelines for the Protection of Human Subjects of Research, or
commonly referred to as the Belmont Report (1979). Although the Belmont Report
(1979) never officially endorsed many of the recommendations, it became the basis for
subsequent DHHS laws. The United States Congress enacted both, titled Protection of
Human Subjects (FDA regulation 21 CFR Part 50 and PHS regulation 45 CFR Part 46;
FDA regulation 21 CFR Part 56 [Institutional Review Boards]); however, there are still,
surprisingly, no national policies to outline protection of human research participants
(Zimmerman, 1997). Zimmerman (1997) notes that the DDHS mandates appear too
“restrictive and inflexible to be used as a dynamic foundation for evolving biomedical
ethics” (n.p.). Despite the lack of endorsement by United States Congress and DHHS,
the Belmont Report (1979) remains widely recognized as an international guideline for
protecting individuals in clinical trials research.
As a result of the Belmont Report (1979) principle, “respect for persons”,
potential participants were no longer considered “passive objects for scientific
investigations or trials but were to be seen as having an inviolable autonomy” (Walker et
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al., 2005, p. 244). Potential research participants were given the opportunity to decide to
participate through adequate information, assessment of comprehension, and most
important, as true and actual volunteers. It was necessary that adequate information
relative to informed potential participants' understanding be given, that “research is
neither necessary for their well being nor are the effects of the research fully known or
understood,” and that “if a direct benefit to subjects is expected, they should clearly
understand the range of risks” (Zimmerman, 1997, n.p.).
The ethical principles outlined in the Belmont Report (1979) were designed to aid
in establishing guidelines for the development of biomedical and behavioral research
with human participants. Respect for persons, beneficence, and justice are the three
fundamental ethical principles that underlie human participation and informed consent
(Walker et al., 2005; NCPHSBBR, 1979). Embedded within these principles are
corollary applications to psychotherapy treatment practices and informed consent. For
example, respect for persons implies that individuals be “treated as autonomous agents”
(Walker et al., 2005, p. 244) and assumes two ethical presumptions. The first assumption
is that people must be treated as autonomous individuals, capable of making their own
decisions by possessing the capacity for self-determination. The other presumption
assumes that not every individual is capable of self-determination; rather, “some
individuals may lose the capacity for self- determination because of physical illness,
mental disabilities, or situations that restrict personal freedom” (Zimmerman, 1997, n.p.).
Beneficence relates to the idea or practice of “doing good” in order to improve an
individual’s overall well-being, and justice dictates that during the treatment process,
every individual must be treated in a manner that is fair and equal (Zimmerman, 1997,
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n.p.). Respect for persons, beneficence, and justice outlined by the APA's Code of Ethics
are embedded in the foundation of informed consent.
Informed Consent Functions
Katz and Capron present an overview of the functions of informed consent; these
are, “to promote individual autonomy; encourage rational decision making; avoid fraud
and duress; involve the public; encourage self-scrutiny by the physician-investigator; and
reduce the civil and or criminal liability of the investigator and his or her institution” (as
cited in Emanuel et al., 2003, p. 198). Information transmission is at the core of
obtaining informed consent (Siminoff, 2003). Informed consent is a moral, ethical, and
legal obligation in medical, psychiatric, and psychological treatment and research (Berg
et al., 2001; Faden & Beauchamp, 1986). Human participant research is regulated by
both federal law (CFR, Title 45, Part 46, 1994) and university or agency Institutional
Review Boards (IRB). These IRB's monitor, design and ensure that informed consent is
consistent with the federal regulations, guidelines and ethics.
There is a clear distinction articulated by researchers between “genuine informed
consent” related to the communication process, and the “bureaucratic trappings” of a
consent form and signature (Emanuel et al., 2003, p. 189). According to Levine (1995),
“genuine informed consent is supposed to serve the rights and welfare of potential
participants in research”, whereas the use of consent forms “largely serves the legal and
financial interests of researchers and their institutions” (as cited in Emanuel et al., 2003,
p. 189). Although the “negotiations for informed consent are designed to safeguard the
rights and welfare of the subject,” Levine (1995) asserts, “documentation that the
negotiations have been conducted properly safeguards the investigator and institution” (as
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cited in Emanuel et al., 2003, p. 198). Although the actual consent signature obtained on
a form for research is advantageous for the investigator, Levine (1995) argues it could
result in privacy and confidentiality violations, resulting in the “net effect” construed as
“harmful to the interests of the subject” (Emanuel et al., 2003, p. 198). Levine (1995)
asserts that, “federal regulations permit wavers of the requirements for consent forms
when the principal threat to the subject would be a breach of confidentiality and the only
record linking the subject and the research would be the consent document” (as cited in
Emanuel et al., 2003, p. 198). This exception, however, does not pertain to the informed
consent process. Federal regulations appear to focus primarily on the consent form itself,
rather than the process as a whole (Emanuel et al., 2003). Information about what is
included and what is excluded on consent forms (both in research and practice) remains
an area of debate. Levine (1995) views informed consent as “a discussion or
negotiation”; Katz, on the other hand, “envisions consent as a searching conversation” (as
cited in Emanuel et al., 2003, p. 198). Researchers generally agree, however, that
informed consent should be viewed as a continual process rather than as a one-time event
(such as obtaining a signature on a consent form).
Although research consent is primarily geared toward “the fulfillment of a
scientific aim,” Roberts, Geppert, and Baily (2002) indicate, “clinical consent is oriented
toward the patient benefit” (p. 292). There is a debate whether or not informed consent to
research should be conducted by a different standard or set of criteria, than informed
consent in psychology practice (Emanuel et al., 2003). Some authors argue it is
unnecessary to negotiate the informed consent process formally when the “interests of
research and practice are conjoined”; however, others argue that there should be “higher

INFORMED CONSENT IN PSYCHOTHERAPY

35

requirements for informed consent... imposed in therapy...particularly when an honest
experimentation is joined with therapy” (Emanuel et al., 2003, p. 198). These researchers
point out that “patients are entitled to the same degree of thoroughness of negotiations for
informed consent as are subjects of research” (Emanuel et al., 2003, p. 198). Although
the bioethics literature and CFR appear to impose more demanding research
requirements, Levine (1995) argues “both patients and research participants should be
afforded the same rigorous protection in this regard” (as cited in Emanuel et al., 2003,
189).
There is, however, with the exception of clinical trials research, no immediate
oversight or monitoring of the informed consent process for psychotherapy practice
(Smith, 2001). As a consequence, there are no clear stated standards or clinical
guidelines on informed consent implementation into the everyday clinical practice.
Although it is generally understood that potential clients should be informed, prior to
engaging in psychotherapy, about the “relative efficacy, efficiency, and safety of the
recommended treatment and its primary alternatives as well as the likely consequences of
no treatment” (Beahrs & Gutheil, 2001, p. 8), the specifics related to informed consent
content and practice appear to be decided on an as-needed basis, depending on the needs
of the client. What constitutes sufficient and appropriate fully informed consent in
clinical practice remains unclear.
The Ethics Codes
In searching for standardized criteria or for guidance about implementation of
informed consent, a review of the major mental health profession's ethics codes and
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guidelines suggests that there are few common elements among the ethics codes related
to understanding and implementation of informed consent.
The medical model. In the precedent setting case, Canterbury v. Spence (1972),
the United States Court of Appeals asserted the following regarding the standards of
informed consent:
(a) that consent is the informed exercise of a choice; (b) that every adult human
being of sound mind has a right to determine what shall be done with his/her
body; (c) that the doctor must disclose all "material risks" based on the "prudent
patient" test; and (d) that the doctor can withhold information from the patient
concerning the risk only if it can be shown that the disclosure would result in
serious adverse psychological consequences to the patient (n.p.).
Judicial decisions have primarily determined standards of disclosure from informedconsent proceedings (Jensen et al., 1991). Knapp and VandeCreek (2006) note
“malpractice courts have used the 'reasonable person' standard to determine what
information should be given to patients” prior to agreeing to undergo a medical procedure
(p. 100). As a guide for physicians, the American Medical Association's (AMA) Code of
Medical Ethics (2006 - 2007) (hereinafter, AMA Ethics Code) has undergone many
revisions since its inception in 1847, and continues to set the standard for practicing
medicine for physicians and health care providers. The AMA Ethics Code asserts that
part of overall good medical practice includes the physician's obligation to his or her
patient to make sure all medical facts are accurately presented in order to be able to make
a treatment decision. With the recent changes in general social policy, the previously
held paternalistic view, whereby physicians tended not to present patients with alternative
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treatment options, in order to ensure patients remaining in treatment, are no longer valid.
There are few, if any, specific guidelines, however, advising physicians about what to
include during informed consent (AMA Ethics Code).
The psychiatric model. Since the first edition of American Psychiatric
Association's (APA) Principles of Medical Ethics (1973), the APA's Board of Trustees
and Assembly have determined numerous editions to these principles; the most recent
include changes in 2001 to the principles. The basic medical-ethical principles of
physician-patient contact are the same; however, the psychiatric profession added some
specific ethical issues. The APA Principles of Medical Ethics (2008) assert “a physician
shall respect the rights of patients, colleagues, and other health professionals, and shall
safeguard patient confidences and privacy within the constraints of the law” (APA,
2008). In regard to providing informed consent, the APA (2008) notes:
Psychiatrists have a long and valued tradition of being essential participants in
organizations that deliver health care. Such organizations can enhance medical
effectiveness and protect the standards and values of the psychiatric profession by
fostering competent, compassionate medical care in a setting in which informed
consent and confidentiality are rigorously preserved, conditions essential for the
successful treatment of mental illness.
Although informed consent in psychiatric practice includes the aforementioned
contractual arrangement between the patient and the physician which is to be “rigorously
preserved”, there is no specific reference regarding informed consent to undergo
psychotherapy or pharmacological treatment as part of establishing the treatment contract
(APA, 2008). The APA (2008) briefly mentions ethics regarding presentation of a case
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to a scientific meeting, during which the physician must ensure “dignity and privacy with truly informed consent,” which includes maintaining patient confidentiality during
presentation (n.p.).
The psychological model. The psychological profession, as a whole, views
informed consent as one of the primary ways of protecting both the self-governing and
the privacy rights of clients. Informed consent is also seen as helping to maintain a
“culture of safety” (Knapp & VandeCreek, 2006, p. 100). The current Ethics Code
(2002) includes broader informed consent requirements, than previous editions, both in
structure and in content (i.e., 1992 edition limited informed consent to research and
therapy). The 1992 Ethics Code marked the first distinction in separating aspirational
from mandatory ethics. The current Ethics Code (2002) reflects the recent societal
changes of moving from a rather paternalistic manner to a more autonomy-based view in
which both professional and scientific ethics are concerned (Fisher, 2003). Fisher (2003)
notes “for the first time clear distinctions were made between aspirational principles that
articulated foundational values of the discipline and specific decision rules articulated in
180 distinct ethical standards that would be subject to enforcement by the APA, other
organizations, and licensing boards that adopted them (Canter, Bennet, Jones, & Nagy,
1994)” (p. 6). The Ethics Code (2002) provides specific guidelines for informed consent
in order to undergo assessments, treatments and research, including provisions for assent
among persons who have limited ability to provide assent. The Ethics Code (2002)
dictates enforceable rules or ethical standards for conduct among psychologists. The
following are outlined by the Ethics Code (2002) regarding minimum standards of
informed consent to therapy:
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(a) When obtaining informed consent to therapy as required in Standard 3.10,
Informed Consent, psychologists inform clients/patients as early as is feasible in
the therapeutic relationship about the nature and anticipated course of therapy,
fees, involvement of third parties, and limits of confidentiality and provide
sufficient opportunity for the client/patient to ask questions and receive answers.
(b) When obtaining informed consent for treatment for which generally
recognized techniques and procedures have not been established, psychologists
inform their clients/patients of the developing nature of the treatment, the
potential risks involved, alternative treatments that may be available, and the
voluntary nature of their participation (Ethical standard 10.01, p. 1072).
In practice, psychologists are obligated to ensure that potential clients have been given
sufficient information in order for them to make an informed decision prior to engaging
in psychotherapy. An informed consent discussion not only protects the rights of client
autonomy and self-direction, but it is thought also to enhance subsequent participation
and responsibility of engaging in psychotherapy (Coyne & Widiger, 1978). The Ethics
Code (2002) indicates that in order to increase client autonomy, psychologists “obtain the
informed consent of the individual or individuals using language that is reasonably
understandable to that person or persons” (Standard 3.10, Informed Consent, p. 1065). In
order to ensure adequate comprehension, careful consideration regarding an individual’s
capacity to understand, includes language at a level the individual can understand and
absorb. If the consenter does not comprehend or understand information presented to
him or her, the informed consent becomes invalid (Zimmerman, 1997). An
implementation of informed consent procedures has been mandated as an ethical
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responsibility for psychologists; however, guidelines concerning the content are vague
and open to individual interpretation. For example, in a discussion of therapeutic risks
and benefits (see Section 10.01b) regarding informed consent, according to the Ethics
Code (2002), appears merely to be implied. An implied discussion allows practicing
psychologists a substantial amount of leeway regarding those topics to be included as part
of a conversation about risks, resulting in significant variation within informed consent
practices.
Informed Consent and Implementation
Research suggests various models to help define the direction of informed consent
and to understand its implementation into the clinical setting (Lidz, Appelbaum, &
Meisel, 1988; Walker et al., 2005). The “event model” is thought of as a onetime event
during which informed consent is given at one specific point in time, usually at the
beginning of treatment; this has its roots in legal doctrine. Because of an emphasis on the
idea that information is more important than the individual's understanding, a consent
form is often used with this model (Braaten & Handelsman, 1997). Lidz et al. (1988)
note some advantages for using this model, including a clear outline of potential client
goals; however, this model is problematic for psychotherapy. The information presented
is often “too complex for the patient to understand without reflection and dialog, and
frequently constitutes a formalistic effort to comply with the law, at the expense of the
real collaboration” (Lidz et al., 1988, p. 1388). Braaten and Handelsman (1997) reveal
“Patients with certain disorders, such as major affective disorders, may be competent to
consent to treatment but may need to be provided with different information once their
symptoms abate” (p. 313). Other problems with this model include the assumption that
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psychotherapy involves only a one-time decision, separate from the process of informed
consent. Not only is this model paternalistic, Braaten and Handelsman (1997) noted “It
provides a poor model for many clients who are seeking treatment in order to regain a
sense of power and autonomy in their lives” (p. 313).
The “process model” on the other hand, addresses informed consent, “as an
integral and continuous part of the relationship between patients and physicians
embedded in the treatment process,” with clients providing active participation in their
treatment decision-making, over time (Lidz et al., 1988, p. 1385). Consent is seen as a
dynamic process which happens within the “context” of the provider-client relationship
(Childress & Fletcher, 1994). The process portion of consent is a “systematic disclosure
of information to the client over time”- over the course of psychotherapy (Reamer, 1987,
p. 428). There is also an element within consent which remains part of the personal
process and tends to be specific to each individuals treatment (Arboleda-Florez, 1987).
The informed consent process provides a more substantial effect on the therapist-client
relationship. Clients are seen to have an active role in the process; this enhances the
interaction between therapist and client, allowing clients the opportunity to make
treatment decisions. This may not only enhance client autonomy and further treatment
goals, it can also “help therapists monitor the course of treatment and, perhaps, provide
therapists with information about their own effectiveness” (Braaten & Handelsman, 1997,
p. 313). Lidz et al. (1988) concluded that the emphasis on the need for participation is
beneficial for the client and “contributes to therapeutic outcomes” (p. 1388).
Most current research view informed consent as a process to be conducted over
time (e.g., Dyer & Bloch, 1987; Hass, 1991). Hass (1991) recommends beginning the
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informed consent process with more general and universal aspects of the proposed
treatment and then moving toward more specific descriptions of procedures and
implications on an as-needed basis. Manning and Gaul (1997) note that when an
individual is experiencing an “emotionally traumatic experience it is difficult to capture
and retain what has been said, let alone the meaning of what has been said” (p. 108).
These authors suggest an “opportunity to reflect, ask more questions that stimulate the
need for specific information” regarding their proposed treatment leads clients to a more
highly informed decision over time (Manning & Gaul, 1997, p. 108).
The phrase “as early as feasible” in ethical standard 10.01a (APA, 2002, p. 1072)
suggests that there may be times when obtaining informed consent during the first
meeting may not be appropriate. Studies suggest that psychotherapy should not be “an
all-or nothing” experience; rather, it should be an on-going process conducted over time
(Pomerantz, 2005). For example, O'Neill (1998) has suggested that potential problems
change in psychotherapy over time, resulting in a need to change a treatment approach;
therefore, a one-time consent presented before these changes occur does not adequately
reflect treatment changes or the consent itself. Stone (1990) regarded informed consent
as a process and not a single set “formula regardless of the actual situation” (p. 425).
Knapp and VandeCreek (2006) suggest “psychologists can sometimes titrate the
information given to patients”, whereby “they present the patient with a limited amount
of information, determine how well the patient is able to understand and integrate that
information, and then provide additional information as needed” (p. 103). Hass (1991)
recommends informed consent be treated as both a prerequisite to engage in
psychotherapy and as part of the ongoing treatment process. Pomerantz (2005) asserts
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that informed consent to psychotherapy “is better conceptualized as a process that
evolves with psychotherapy rather than as single even that precedes it” (p. 352).
Faden and Beauchamp (1986), as outlined by Walker et al. (2005), describe two
requirements for informed consent. First they reveal that informed consent is an actual
“authorization of treatment by an informed and intentional patient”, whereas the second
is “more of an institutional one that observes the correct legal means for obtaining
consent” from individuals seeking psychotherapy (Walker et al., 2005, p. 244). With the
second one there is a greater emphasis on meeting the legal requirements, which include
the consent signature being a “defining moment of the consent process” (Walker et al.,
2005, p. 244). Rather than merely signing a consent form, these researchers assert that
“clients should more than simply comply with treatment: they should actively authorize it
as autonomous agents or take the opportunity to exercise control over their decisions”
(Walker et al., 2005, p. 244). Dyer and Bloch (1987) viewed the clinical informed
consent process as occurring “within the framework of a fiduciary relationship whereby
therapists identify specific needs of patients and respond individually without the use of
written contract or forms” in which this “fiduciary relationship is one based on mutual
trust, confidence, and openness” (as cited in Braaten & Handelsman, 1997, p. 313).
The manner in which informed consent is obtained in research has significant
application to the informed consent process in practice. Obtaining informed consent to
undergo research and treatment in clinical trials, “has become a routine expectation as a
way to promote self-determination and autonomy” (Walker et al., 2005, p. 243).
Although informed consent procedures among research settings has received a significant
amount of attention and has resulted in formal consent procedures (regulated by IRB in
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academic settings), there is less evidence for protection of clients either by completed
procedures or by guidelines among clinical practice settings. In fact, Hare-Mustin,
Marecek, Kaplan, and Liss-Levinson (1979), reveal that in their opinion, the primary
motivating factors for the use of informed consent procedures for psychotherapy were
therapist's protection from malpractice lawsuits and as a way to safeguard psychology
from outside regulation. Regardless of the rationale, Handelsman, Kemper, KessonCraig, McLain, and Johnsrud (1986) emphasize the importance of providing written
information to clients at the onset of psychotherapy. Knapp and VandeCreek (2006)
suggest the “content of informed consent procedures is intended to anticipate questions
that most reasonable patients would have and to prevent future misunderstandings and
disappointments” (p. 100). The ultimate goal for these consent procedures (provided
correct implementation) consists of “open exchanges between psychologists and their
patients” (Knapp & VandeCreek, 2006, p. 100).
The ethical responsibility of psychologists to practice informed consent is clear;
however, there is little consensus regarding procedures related to the use of oral or
written consent forms for psychotherapy (APA, 2002; Everstine et al., 1980; Hare-Mustin
et al., 1979; Morrison, 1979; Schwitzgebel, 1976). Muehleman, Pickens, and Robinson
(1985) note that no more than one-third of practicing psychologists use verbal consent
from their clients for psychotherapy. Authors have advocated that written forms include
a description of goals, procedures, risks, and benefits for psychotherapy (Hare-Mustin et
al., 1979; Handelsman & Gavin, 1988; Morrison, 1979). Handelsman and Gavin (1988)
advocate for a combination of an informed consent format which includes an initial
written section in which clients indicate information that interests them, with concerns
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subsequently addressed orally by the therapist before initiation of therapy. These authors
present a written format that includes open-ended questions that a client has the right to
ask upon entering psychological treatment. An open-ended format “has several
advantages over narrative forms: it preserves clients' right to refuse information; it is less
overwhelming; it fosters conversation between therapist and client, and it is readable”
(Handelsman & Gavin, 1988, p. 223).
Research is varied regarding the use of consent forms. For example, in a survey
study of psychologists in private practice, 28 percent of those who responded (53 percent)
endorsed using an informed consent form; the primary reason for not using a form is a
preference for oral informed consent (Handelsman et al., 1986). Results from this study
reveal forms from psychotherapy practice generally dealt with fees and not “information
that satisfies the requirements of informed consent, such as risks of treatment and
alternative treatments” (Handelsman et al., 1986, p. 514). Among the 19 consent forms
collected in their study, only one mentioned possible risks, and none of the consent forms
outlined “benefits or risks to be expected of alternative treatments, or prognosis without
treatment” (Handelsman et al., 1986, p. 516). Although Handelsman et al. (1986) note
that they do not necessarily endorse using a consent form, they articulate “increased
sensitivity to the issues involved”, including the fact that the potential risks are of
primary importance (p. 516). Hare-Mustin et al. (1979) argue strongly for information
related to risks involved and for alternative treatment to be included, at the onset of
psychotherapy, in any informed consent procedure.
Handelsman et al. (1986) note that because consent forms do not necessarily
guarantee informed consent, more sensitivity to the issues involved is warranted.
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Croarkin, Berg, and Spira (2003) note “state psychological associations have examined
these procedures and recommend that patients be offered documents at the outset of
treatment” (p. 399). Researchers suggest presenting clients with “a patient's rights form,
treatment-contract form, and an informed-consent form” at the beginning of treatment
(Croarkin et al., 2003, p. 399). Giving a client these forms, according to Horowitz
(1984), not only emphasizes the voluntary nature of engaging in psychotherapy, but also
that there are inherent risks which clients need to know about. Addressing risks,
including potentially negative treatment effects during the informed consent process
appears consistent with these fundamental goals of informed consent, as part of creating a
dialog or exchange between clients and psychologists.
Informed Consent and Risk
One of the main responsibilities of psychologists is to ensure the informed rights
of their clients relative to potential risk (Hare-Mustin et al., 1979). Handelsman and
Gavin (1988) assert “therapists still must judge whether a given risk or alternative is so
important that a particular client absolutely needs to know, they must answer the
questions objectively and clearly, and they must ensure that clients understand and are
satisfied with the material presented” (p. 224). One of these responsibilities includes
providing individuals with the knowledge of potentially negative effects as a result of
psychotherapy. Information regarding what constitutes risks or negative indirect effects
is essential in order for a client to be able to weigh the benefits and risks upon entering
treatment (Hare-Mustin et al., 1979). The psychology profession has been “more
proactive in regard to establishing informed consent for psychotherapy as a standard of
care” (Croarkin et al., 2003, p. 399); however, there is considerable variability among
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practices regarding addressing risk during the informed consent process (Handelsman et
al., 1986; Noll & Haugan, 1985).
Although there is published literature suggesting informed consent content, less is
known about clinicians' actual informed-consent procedures. Most of the research in the
area of informed consent consists of surveys reporting alleged informed consent content
among consent forms. Although there is clear responsibility on behalf of psychologists to
inform their clients fully about potential risks related to psychotherapy, an adequate,
outlined procedure appears to be lacking. Subsequently there appears to be little
agreement about what those potential risks should include. In their study examining
opinions and practices of psychotherapists, Croarkin et al. (2003) reveal that practices for
informed consent vary with the characteristics of the therapists. Results from content
analyses of written consent forms reflect a wide variation of information used by
psychologists (Handelsman et al., 1979). In their study, Talbert and Pipes (1988)
conducted a content analysis of 40 consent forms used by psychological services. Results
indicated inconsistent content, and only 1 of the 40 forms mentioned possible risks of
engaging in psychotherapy. However, Somberg et al., (1993) surveyed psychotherapists’
attitudes and beliefs regarding informed consent, including potential risks of
psychotherapy. Data revealed that 48 percent of clients were informed about risks
(Somberg et al., 1993). Noll and Haugan (1985) reported similar results, indicating that
approximately 40 percent of psychologists inform their clients about potential risks (e.g.,
confidentiality issues). However, a discussion of potential risks by the clinician,
according to Noll and Haugan (1985), was more highly preferred when relevant
situations presented during the course of psychotherapy. One reason for delayed
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presentation of possible risks of therapy, Noll and Haugan (1985) hypothesize, is that
clinicians may feel information of risks could potentially overwhelm possible clients and
deter them from engaging in psychotherapy. Results from a study conducted on a
German speaking population, Dsubanko-Obermayr and Baumann (1998) found that a
higher percentage (68 percent) of clients were informed of risks during informed consent
when compared with the results of Stomberg et al. (1993) and Noll and Haugan (1985).
A possible reason for the apparent difference, according to Dsubanko-Obermayr and
Baumann (1989), may be “explained by a different comprehension of the term 'risk' (e.g.,
family changes, straining periods, failure of therapy, stigma, and so on)” (p. 243).
Although addressing risks in therapy may be considered generally relevant, more
research is needed regarding psychologists' attitudes and practices related to addressing
potential negative effects of psychotherapy during the informed consent process.
As part of the information process, Hare-Mustin et al. (1979) assert the need to
include, as part of a conversation of risk, potential negative effects as a result of engaging
in psychotherapy (Hare-Mustin et al., 1979). Braaten and Hadelsman (1997) found both
current and former therapy clients wanted information about confidentiality, risks of
alternative treatments and inappropriate therapeutic techniques as opposed to information
such as therapist personal characteristics and professional training, which were rated as
least important. Similarly, in their study looking at what client's considered preferable
information during informed consent, Jensen et al. (1991) surveyed 173 parents of
elementary school-aged children regarding potential psychotherapy for their children.
The parents placed a stronger emphasis on disclosure of information related to iatrogenic
risks then did the therapists (Jensen et al., 1991). Prior to the onset of psychotherapy, 95
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percent of the parents wanted information about therapeutic risks (Jensen et al., 1991). In
an earlier study conducted by the same authors (Gustafson, McNamara, Jensen, 1988),
child clinical psychologists were surveyed and rated iatrogenic risk as only moderately
important information to include during informed consent. Interestingly, however, there
appeared to be a high correlation among these child psychologists between therapeutic
risk-benefit importance ratings and their reported frequency of discussion of such issues
with their clients (Gustafson et al., 1988). In a national survey study on psychotherapy
outcome, Boisvert (1999) found respondents to be “either incorrect about research
findings on iatrogenic effects (i.e., they tended to underestimate the frequency of negative
outcomes) or simply indicated that they were unaware of research in this area” (as cited
in Boisvert & Faust, 2002, p. 247). Dsubanko-Obermayr and Baumann (1998)
concluded, as a consequence of clients not being well informed of risks within the first
five sessions of therapy, consent to psychotherapy was deemed insufficient. Pomerantz
(2005) surveyed licensed psychologists regarding the timing of informed consent; they
asked what the psychologists felt, specifically, was the earliest point in time at which they
could provide information regarding specific aspects of therapy, including risks and
alternatives. The general consensus among psychologists include requiring “about one
full session of psychotherapy to feel capable of addressing the many important aspects of
psychotherapy” including risks (Pomerantz, 2005, p. 356). In another study Sullivan,
Martin, and Handelsman (1993), instructed participants to rate their initial impressions of
therapists that use either oral or written informed consent procedures, including
information related to risk or benefits of treatment, or of therapists that use no informed
consent. Participants gave higher ratings to those therapists who used an informed
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consent procedure and were more willing to recommend the therapist to a friend and go
to him or her for therapy (Sullivan et al., 1993). Psychology professionals who used an
informed consent procedure were rated as more “expert and trustworthy” then those who
did not (Sullivan et al., 1993, p. 160).
Informed Consent Biases
Knapp and VandeCreek (2006) assert that the “standards of informed consent
were developed primarily from physical medicine or surgery, and the degree to which
they apply to mental health treatment is controversial” (p. 100). As one of the most
arguable components of informed consent, the APA's Code of Ethics (2002) briefly
mentions the ethical need to inform clients of the benefits and risks of treatment.
Although this is a clear standard of practice when psychotropic medications are involved
(due to pharmacological side effects), it is less clear when it comes to psychotherapy.
Plaut (1989) notes “the apparent trade-off between, on one hand, increased autonomy,
reduced dependency and increased participation by the patient and, on the other hand,
decreased trust in the physician, is a difficult one” (p. 436), and continues to produce
ethical dilemmas for clients, psychologists and attorneys. Although “informed consent is
not an optional process,” Braaten, Otto, and Handelsman (1993) reveal “client
preferences are not the final determining factor in what information psychologists
provide” (p. 569). These authors reveal that “the fundamental functions of informed
consent, to promote individual autonomy and to encourage rational decision making are
paramount” and “psychologists need to follow the disclosure guidelines mandated by
ethics codes and state laws” (p. 569), Braaten et al. (1993) conclude that if the
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psychological profession follows only what is “absolutely required they may be missing
the opportunity to provide the most good for clients” (p. 569).
Ethicists and researchers agree that informed consent is at the core of moral
practice in both medicine and treatment; however, it may be perceived as less important
in clinical practice settings then in treatment setting for a several reasons (Pellegrino &
Thomasma, 1993). Practicing psychologists may have a limited understanding of the
informed consent process because they have insufficient training for providing fully
informed consent (Walker et al., 2005). There may also be an attitude bias among
psychologists toward the client's level of competence to give accurate, informed consent
to engage in psychotherapy. For example, the literature on competence tends to focus
more closely on severe mental illness impairment (i.e. mental retardation, dementias,
severe cognitive impairment); depending on the circumstances, these impairments could
make it difficult for clients to give their full consent to psychotherapy (Grisso &
Appelbaum, 1998; Elliott, 1997). According to Grisso and Appelbaum (1998), the
criteria for a client to make an informed decision include the ability to express his or her
choice, understand relevant information, appreciate the significance of the situation and
the choices, and reasonably weigh options (see also Historical Factors of Informed
Consent). In research, however, clients with depressive disorders (with the exception of
psychotic depression) are typically considered competent to give consent to undergo
research involving medical treatments (Appelbaum, Grisso, O’Donnell, & Kupfer, 1999).
In their study of moderately depressed, outpatient women with major depressive disorder,
Appelbaum et al. (1999) found participants “performed quite well on a measure of their
decision-making capacities related to research” (p. 1383). These authors note that few
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participants “manifested difficulties with understanding, appreciation, or reasoning to a
degree that would raise suspicions about their capacity to make an informed choice...the
extent of depressive symptoms did not seem to affect the level of performance”
(Appelbaum et al., 1999, p. 1383). Researchers find that participants who suffer from
severe mental illness (i.e., schizophrenia and bipolar disorder) have also been found
competent to understand and retain informed consent information; however, when
compared with medically ill participants, they are reported to have less understanding of
consent information (Flory & Emanuel, 2004; D. Wirshing, W. Wirshing, Marder,
Liberman, & Mintz, 1998). In clinical practice settings, an individual entering into
psychotherapy should be thought of as being able to understand and to give their fully
informed consent to treatment, regardless of their subsequent mental illness or current
diagnosis, as defined in the APA Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV-TR).
Meisel, Roth, and Lidz (1977) indicate that “if all risks and possible consequences
of the procedure in question, and all alternative procedures are presented to the patient
and the patient has given evidence that the presentation was understood” then consent is
thought to be informed (as cited in Widiger & Rorer, 1984, p. 508). However, some
authors recount that it may not always be appropriate to disclose all relevant and
important information when a client, according to Morse (1967), is experiencing
“instability, distress, [and] confusion” (as cited in Widiger & Rorer, 1984, p. 508).
Meisel et al. (1977) note, “if disclosure of certain information-especially the risks of
treatment is likely to upset the patient so seriously that he or she will be unable to make a
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rational decision, then the physician has the 'therapeutic privilege' to withhold such
information” (p. 282).
Other potential biases regarding informed consent implementation, according to
Braaten and Handelsman (1997), include therapist's concern over the impact on the
therapeutic relationship, the client's view of the therapist's ability to help him or her,
resulting in the possibility of client drop-out. These authors suggest that because the
modal length or therapy is one session (Talmon, 1990), and studies reveal drop-out rates
for psychotherapy to be within the first three to five sessions (Garfield, 1986), therapists
may not be presenting adequate “useful information at the beginning of counseling”
(Braaten & Handelsman, 1997, p. 313). However, the “promotion of autonomy and
rational decision making is thought to enhance and help define the relationship between
client and therapist” (Braaten & Handelsman, 1997, p. 312); it should not negatively
impact it.
Beahrs and Gutheil (2001) recommend an integration of clinical aspects of
informed consent along with the legal requirements; this might be done verbally, with
documentation of the client's “level of interest and understanding in the written record”
(p. 8). Although the written consent meets, more closely, a legal criterion, Beahrs and
Gutheil (2001) assert “written contracts with patients run the risk of sacrificing clinical
rapport so essential to positive therapeutic outcome and fail to address new questions that
emerge” (p. 8). Although the “burden of the therapist to provide informed consent varies
with the particular client, the clinical problem at hand, and the social context”, Beahrs
and Gutheil (2001) assert, “these burdens increase directly with the costs and risks of the
recommended treatment” (p. 8). Beahrs and Gutheil (2001) note that regardless of how
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“the process is implemented, it is important that patients understand that multiple options,
including no treatment exist - each with different rationales, methodologies, and
risk/benefit profiles” (p. 8).
There are no guarantees that all clients will fully comprehend and understand
potential negative effects of psychotherapy; however, having clinical guidelines for
informed consent would help ensure clients and therapists be provided with the best
available knowledge of these matters. Boisvert and Faust (2003) note “if therapists are
unfamiliar with the domain of knowledge in psychotherapy research, the information
provided on these types of matters [negative treatment effects] pertaining to informed
consent is likely to be personal opinion and may not align with the research evidence” (p.
512). Similarly, “if a therapist's views deviate from consensus opinion among experts,
clients should be informed of both positions and the strength of the evidence on which
each rests” (Boisvert & Faust, 2003, p. 512). Ensuring that the client gives truly
informed consent for psychotherapy is an essential part of psychologists fulfilling the
ethical obligations and legal requirements of informed consent.
Approximately 400 studies in the last decade have addressed information on
informed consent (Sugarman et al., 1999). However, a review of informed consent
literature related to risk reveal that there have been few published studies related to
psychologists informing clients of potentially negative effects of psychotherapy during
informed consent processes. All the previously mentioned studies looked at the problem
of negative treatment effects, general informed consent procedures, and information
related to what clients and clinicians considered important. There is a need to survey
doctoral-level, licensed psychologists on negative treatment effects and to inquire how
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they practice fully informed consent. This current survey study has intended to assess
licensed psychologists’ attitudes toward and practices pertinent to, addressing negative
effects of psychotherapy during informed consent process. Because of the considerable
research on negative effects of psychotherapy, licensed psychologists were surveyed on
attitudes and subsequent practices toward these negative treatment effects related to
informed consent practices.
It has been hypothesized that addressing negative effects of psychotherapy during
informed consent may have negative implication for treatment. In their study, Braaten
and Handelsman (1997) surveyed patients, former patients, and non patients on attitudes
toward informed consent and the importance of being informed about the risks of
psychotherapy. These researchers found former clients “placed more of an emphasis on
risk of counseling than did one or more of the other groups, possibly because they had
more experience with some of the potential problems inherent in counseling” (p. 323).
These authors point out “that although it has been suggested that clinicians may withhold
information about treatment risks because of concerns about potential negative effects on
clients (Handelsman et al., 1986; Noll & Haugen, 1985), people who have been through
the therapy process value the information” (p. 323). Jensen et al. (1991) point out those
psychotherapists might “curtail disclosure about therapeutic risks, fearing such
information might deter potential clients from engaging in therapy” (p. 168). This
“attitude,” the authors reveal, “may particularly reflect clinicians' tendencies to
systematically underestimate the importance of discussion of certain issues, particularly
therapeutic risks, in informed-consent contexts” (Jensen et al., 1991 p. 168). The authors
note that some potential psychotherapy clients might “not only tolerate this type of
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discussion, they might welcome such disclosure” (Jensen et al., 1991 p. 168). Other
studies suggest that consumers of psychotherapy value a risk-benefit discussion, even if
the information disclosed is not necessarily used in their treatment decisions (Denney,
Williamson, & Penn, 1976; Faden & Beauchamp, 1980; Gustafson, 1988).
Informing clients of the potential risks of engaging in psychotherapy, including
the fact that treatment might not work for everyone, is a fundamental part of obtaining
truly informed consent. The potential risks of negative treatment effects (including
iatrogenic and deterioration effects) might appear initially less severe with talk therapies;
however, they are just as important as the potential risks of psychopharmacological side
effects. Informing clients in full regarding risks and benefits to treatment, not only gives
them the option of choice, but it also helps them recognize the importance of being part
of their own treatment and therapy. More information is necessary in order to understand
how psychologists comprehend and implement informed consent in their own
psychotherapy practices. Although it is clear that most psychologists receive education
on ethics and informed consent in graduate school and post-doctoral studies, guidelines
that outline the application of the Ethics Code (2002) appear vague and incomplete.
More research is sorely needed so that psychologists may better understand these issues
in clinical practice. Because there is such little information on the clinical practice
related to addressing potential negative treatment effects of psychotherapy during the
process of informed consent, this survey study is somewhat exploratory.
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Chapter Three: Hypotheses
Specific Hypotheses and Questions
The research question for this study was based on informed consent research and
theory from the past several decades (e.g., Bergin, 1971; Strupp et al., 1977; Mohr, 1995;
Stricker, 1995; Boisvert & Faust, 2003; APA, 2002), establishing the notion of informing
clients of potential risk as being integral to the informed consent process. The informed
consent doctrine mandates that discussion of potential negative effects directly resulting
from psychotherapy is a necessary component of informed consent (Jensen et al., 1991).
The hypotheses for this survey study presume that licensed psychologists obtain, at some
point prior to beginning psychotherapy, informed consent from their potential clients. A
relative standard of disclosure and lack of specific clinical guidelines regarding informed
consent indicate a need for research investigating the attitudes and practices of currently
licensed psychologists. Empirically supported, informed consent is currently
recommended for psychotherapy; however, the question of informing clients as part of a
discussion of risks, potential negative effects associated with psychotherapy, remains
unclear. The following research hypothesis was proposed:
Hypothesis 1. Licensed psychologists who acknowledge the significance of
potential negative effects associated with psychotherapy are more likely to inform their
clients of risks associated with negative treatment effects.
Rationale. Research findings suggest there appear to be similarities in the
reported ethics and belief systems of psychotherapists and their subsequent practices
(Somberg, Stone, & Claiborn, 1993; Pope, Tabachnick, & Keith-Spiegel, 1987).
Therefore, licensed psychologists who endorse congruent scores on the survey related to
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the occurrence of negative treatment effects as a result of psychotherapy are expected to
subsequently inform clients of potential risk regarding negative treatment effects.
Hypothesis 2. The second area of investigation posed the question: Are licensed
psychologists hesitant to address negative effects of psychotherapy due to the belief that
it will negatively impact the therapeutic alliance and subsequent psychotherapy outcome?
It was hypothesized that licensed psychologists will rate the addressing of potentially
negative treatment effects associated with psychotherapy as less important if they believe
that it will negatively affect the therapeutic alliance and psychotherapy outcome.
Rationale. Braaten and Handelsman (1997) discuss potential biases that
psychologists hold relative to informed consent implementation. There is concern among
practicing psychologists relative to addressing potential negative effects of
psychotherapy, concerning how this might impact the therapeutic relationship, the client's
view of the therapist's ability to help him or her, and subsequent client drop-out (Braaten
& Handelsman, 1997). Braaten and Handelsman (1997) note that providing useful and
relevant information at the beginning of the informed consent process may improve
psychotherapy outcome. Research reveals a discrepancy concerning what clients and
clinicians rate as important information to be included during informed consent. In their
study of parents seeking therapy for their children, Jensen et al. (1991) revealed that
therapists rated a discussion of informed consent issues, particularly therapeutic risks,
less important than did parents. Therefore, it is expected that licensed psychologists who
endorse greater risk of negatively impacting the therapeutic alliance and subsequent
treatment outcome, will be less likely to inform clients of potential negative effects of
psychotherapy, during informed consent.
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Hypothesis 3. The third area of investigation poses the question: Are certain
demographic characteristics (degree, theoretical therapeutic orientation, career setting,
clinical experience, and post-doctoral ethics training) among licensed psychologists
related to attitudes and/or practices of informed consent procedures? It was hypothesized
that the number of years of clinical experience, post-doctoral ethics training, and a
Cognitive-Behavioral orientation, would positively correlate with licensed psychologists’
attitudes regarding the importance of including risks of potential negative effects of
psychotherapy during the informed consent process.
Rationale. Psychologists who have more experience in the practice of
psychology are also presumed to have more contact with clients and subsequent ethical
situations. Similarly, those psychologists who have attended post-doctoral ethics training
are presumed to have received information on the process of informed consent and
disclosure of risks. The Cognitive-Behavioral orientation lends itself toward encouraging
autonomy in their clients. In fact, Somberg et al. (1993) revealed in their study
“therapists of a Cognitive-Behavioral orientation indicated they inform clients more often
and consider the issues more important” than therapists from other therapeutic
orientations (p. 153). With such a strong emphasis on the client’s taking an active role in
treatment, it seems that psychologists whose primary orientation is Cognitive-Behavior
Therapy (CBT) would be more likely to encourage client participation in a discussion of
risks during the process of informed consent. However, whether or not licensed
psychologists from a CBT orientation inform clients of potential risks of negative
treatment effects as a result of psychotherapy, during the process of informed consent,
remains unknown.
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Chapter Four: Method
Overview
The present study focused on licensed psychologists' attitudes and practices
related to addressing potential negative effects of psychotherapy during the informed
consent process. This research study included a nationwide sample of licensed
psychologists' attitudes and practices toward many of the issues raised in the literature
regarding risk and the ethical implementation of informed consent procedures.
Design and Design Justification
A survey research design strategy was used for the proposed investigation. No
identifying information was collected. The study utilized a survey-based research design
(questionnaire format) in order to assess licensed psychologists’ attitudes and practices
related to addressing potential negative effects of psychotherapy during the informed
consent process.
Data Reporting and Entry. The survey questionnaire utilized a Likert-type
scale. Responses were placed in a numerical format for analysis. All data from
completed on-line survey questionnaires using SurveyMonkey were subsequently entered
into a spreadsheet database for final analysis, using Statistical Software for the Social
Sciences (SPSS 16.0). Descriptive statistics were examined including frequency,
distribution, mean, median, standard deviation, and standard error. A correlational
analysis (using a Pearson product-moment correlation coefficient) was the preferred
means to determine the relationship between general attitudes toward negative treatment
effects of psychotherapy and addressing those risks during the process of informed
consent. Between-group comparisons were conducted by means of one-way analyses of
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variance (ANOVA) in order to assess for group differences. An analysis was conducted
on demographic data in order to ascertain correlations on attitudes regarding informed
consent practices and negative treatment effects.
Participants
The nationwide sample consisted of 161 completed surveys from licensed
psychologists. Qualified participants included male and female licensed psychologists,
defined as mental health professionals who apply scientifically validated procedures to
help people change their thoughts, emotions, and behaviors (APA, 2008). For the
purposes of this study, psychotherapy, according to the APA (2008) was defined as,
“treatment of emotional or behavioral problems by psychological means” (p. 1-5). It
includes a collaborative effort between an individual and a psychotherapist and provides
a supportive environment to talk openly and confidentially about concerns and feelings.
For this study, psychologists were included in this sample provided they were: 1) licensed
to practice psychology in the state where they practice or in some other state; 2) hold a
Doctoral degree in a mental health related field, and 3) have an available electronic mail
address.
Notice for participant recruitment was sent out through electronic mail obtained
on various websites over the World Wide Web; these included: National Directory of
Psychologists, The Association of Black Psychologists, and graduate school psychology
programs listed on the APA directory. Participation in this study was on a voluntary
basis. Participants gave consent by choosing to accept the prompt NEXT at the
beginning of the on-line questionnaire presented in Appendix A and B. Participants in
the study were free to withdraw from the study for any reason, at any time and were
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treated in accordance with the Ethics Code (2002). Participants were excluded if they 1)
did not hold a Doctoral level degree, 2) were not licensed to practice psychology in a
state where they practice or in some other state, and 3) did not have an available
electronic mail address.
Measures
The instrument used in this survey study was a questionnaire developed
specifically for this study, designed to capture attitudes and practices that licensed
psychologists hold regarding informed consent practices, specifically related to risks of
informing clients of potential negative effects of psychotherapy. The survey included
definitions from research regarding potential risk of negative effects (iatrogenic and
deterioration effects) attributable to psychotherapy. These definitions included: no
positive meaningful change, worsening of a symptom/condition, appearance of new
symptoms, heightened concern regarding existing symptoms, excessive dependency on
therapists, reluctance to see future treatment, the abuse or misuse of psychotherapy by the
client, the client “overreaching” himself or herself , and physical harm (Lilienfeld, 2007;
Boisvert & Faust, 2003; Nolan, 2004; Mercer, Sarner, & Rosa, 2003). The questionnaire
consisted of 27 questions in total. The initial section of the questionnaire included selfreport questions (dependent variables) on attitudes and practices related to informing
their clients of potentially negative treatment effects during the informed consent process.
The latter portion of the survey included demographic characteristics (independent
variables): (a) gender, (b) age, (c) ethnicity, (d) number of years working as a licensed
psychologist, (e) populations served, (f) practice location, (g) theoretical therapeutic
orientation, and (h) post-doctoral ethics training, etc. These variables have been studied
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in relation to a variety of ethical issues (e.g., Borys & Pope, 1989; Pope, Tabachnick, &
Keith-Speigel; Somberg, Stone, & Claiborn, 1993). Responses on the questionnaire were
rated by using a response key on a 7-point Likert scale (i.e., Strongly Agree=1, to
Strongly Disagree=7; and Very Unimportant=1, to Very Important=7), true of false, and
options from a drop down menu.
Procedure
After an extensive literature review (conducted using PsycINFO) on informed
consent and psychotherapy, it became apparent that there was a significant gap in both
the research and clinical literature related to the clinical implementation of informed
consent procedures using the APA’s Ethics Code. Although studies on informed consent
and risk are available, addressing potential negative effects as a result of engaging in
psychotherapy did not appear to be emphasized. Further, there are limited guidelines and
implementation procedures, about when or how to inform clients of potential negative
effects as a result of psychotherapy. Research is lacking relative to information on
practicing psychologists’ attitudes regarding their own informed consent procedures, and
relative to whether or not they address potential negative effects as a result of some
aspect of psychotherapy with their clients.
The questions on the survey were chosen in order to capture licensed
psychologists’ attitudes and practices of the informed consent process, specifically
related to potential negative effects as a result of psychotherapy. Participants were
instructed to respond to the survey questions regarding each of the 27 items. The next
step was to pilot the questionnaire on a small number of psychology faculty at the
Philadelphia College of Osteopathic Medicine (PCOM). The questionnaire was
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examined for clarity, grammatical errors, and order of questions. Efforts were made to
enhance the presentation, the attractiveness, and the appeal of the questionnaire, because
this has been found to entice the respondent to complete it (Dommeyer, 1988). In
addition, both positively and negatively worded items were included to eliminate
potential acquiescence bias (Smyth, Dillman, Christian & Stern, 2007; Nunnally &
Bernstein, 1994).
Surveys were distributed to 2,148 currently licensed psychologists through
professional psychological associations and societies using their electronic mail address;
through this method, 161 completed surveys were obtained. The electronic mail included
a brief description of the study and website address that directed potential participants to
the questionnaire on SurveyMonkey over the World Wide Web (Appendix A). The
participants were able to give their consent to participate in the study by clicking on the
NEXT button at the beginning of the on-line questionnaire. No personal identifying
information was collected and steps were taken to protect participant’s anonymity.
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Chapter Five: Results
A nationwide sample of 2,148 potential participants was solicited through their
electronic mail address to participate in the survey. A total of 161 doctoral level
psychologists chose to participate in the study. The overall response rate was 7.5% for
completed on-line questionnaires. The survey contained a total of 27 items. The initial
part of the survey contained questions related to licensed psychologists' attitudes and
practices of obtaining informed consent, specifically related to addressing potential
negative treatment effects of engaging in psychotherapy (Appendix B). These first 14
questions were measured through various scales including a seven-point Likert scale; this
was coded from 1 to 7 on agreement (Strongly Agree=1, Moderately Agree=2, Slightly
Agree=3, Neutral=4, Slightly Disagree=5, Moderately Disagree=6, Strongly Disagree=7),
and 1 to 7 on importance (Very Unimportant=1, Moderately Important=2, Slightly
Unimportant=3, Neutral=4, Slightly Important=5, Moderately Important=6, Very
Important=7), Yes or No, and last, by picking an option from a list of multiple choice
items. The second half of the questionnaire captured demographic information from
participants. The latter portion contained 13 questions coded on a multiple choice or
drop down menu format. Every item on the survey questionnaire was calculated for
percentages.
Demographic Information on the Study Sample
The majority of the sample was Caucasian (90.2%) and evenly split between
males (49.6%) and females (50.4%). The age of the participants varied, with 26.7%
between the ages of 59 and 74, 38.3% between the ages of 44 and 59, and 35.0% between
the ages of 31 and 44. The majority of the participants hold a Ph.D. degree (82.8%), with
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the rest possessing a Psy.D. degree (15.7%) and Ed.D. degree (1.5%). The majority of
participants have a primary emphasis in clinical psychology (85.1%), with the rest
endorsing counseling (7.5%), and other (7.4%) areas of emphasis. The most frequently
endorsed orientation was Cognitive/Behavioral (46.9%), with Psychodynamic (16.9%)
and Interpersonal (13.1%) following next. The least endorsed orientation was the
Behavioral (10.0%); the rest endorsed other areas of emphasis (13.1%). Most of the
participants (93.9%) do not hold an American Board of Professional Psychology (ABPP)
specialty certificate. The majority of the sample has practical experience working with
an adult (75.8%) and older adult (28.9%) population, with adolescent (44.3%) experience
next and working with the child (28.2%) population somewhat less frequently. It should
be noted that participants were able to endorse more than one population. The most
frequent therapy modality reported was with individual (76%) clients, with families
(10.1%), groups (8.5%); couples (54%) was rated less frequently. It should be noted that
participants were able to choose more than one modality; however, 32 participants chose
not to answer the question. Half of participants (50.4%) reported primary work in
academic settings (college or university), with solo independent practices (41.4%) rated
next, group practices (12.0%); research (10.5%) was somewhat less frequent and
community mental health centers (8.3%) and hospital setting (8.3%) were the least
frequently reported. It should be noted that participants were able to pick more than one
modality and 28 participants chose not to answer the question. Participant work
experience in the field of psychology is categorized into three groups: more than 30 years
(20.2%), 5 to 10 years (23.4%), and 11 to 15 years (16.9%). The demographic data
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obtained are similar to results obtained from a nationwide survey (see page 90). (Table 1
presents the demographic characteristics in detail.)
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Table 1
Demographic Characteristics of the Sample
________________________________________________________________
Demographic

Percentage

________________________________________________________________
Gender
Male

50.4

Female

49.6

Ethnicity
Caucasian

90.2

African American

2.3

Hispanic

2.3

Native American

0.8

Asian/ Pacific Islander

2.3

Multi-Racial

2.3

Education
Ph.D.

82.8

Psy.D.

15.7

Ed.D.

1.5

ABPP*
None

93.9

________________________________________________________________
*American Board of Professional Psychology specialty certificate

68

INFORMED CONSENT IN PSYCHOTHERAPY
Table 1-cont.
Demographic Characteristics of the Sample
________________________________________________________________
Demographic

Percentage

________________________________________________________________
Age
Between age 59- 74

26.7

Age 44 – 58

38.3

After age 31 – 44

35.0

Doctoral Degree Emphasis
Clinical

85.1

Counseling

7.5

Developmental

3.0

Educational

1.5

School

2.2

Social

0.7

Orientation
Cognitive/Behavioral

46.9

Behavioral

10.0

Psychodynamic

16.9

Interpersonal

13.1

Systems

13.1

________________________________________________________________
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Table 1-cont.
Demographic Characteristics of the Sample
________________________________________________________________
Demographic

Percentage

________________________________________________________________
Primary Population Served*
Child

28.2

Adolescent

44.3

Adult

75.8

Older Adult

28.9

No. Years Working in Psychology
Less than 5 years

4.8

5 to 10

23.4

11 to 15

16.9

16 to 20

9.7

21 to 25

13.7

26 to 30

11.7

More than 30 years

20.2

________________________________________________________________
*Participants were able to rate more than one choice.
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Table 1-cont.
Demographic Characteristics of the Sample
________________________________________________________________
Demographic

Percentage

________________________________________________________________
Therapy Modality*
Individual

76.0

Family

10.1

Group

8.5

Couple

54.0

Primary Work Setting*
Academia

50.4

Solo Independent Practice

41.4

Research

10.5

Community Mental Health
Group Practice

8.3
12.0

Hospital

8.3

Treatment facility

2.3

School

2.3

Correctional facility

1.5

Administration

1.5

________________________________________________________________
*Participants were able to rate more than one choice.
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Frequent Attitudes Endorsed in the Study Sample
Data describing attitudes related to informed consent practices, specifically
toward potential harm from engaging in psychotherapy, include the following: general
ethics and informed consent practices, risks and potential negative treatment effects,
therapeutic treatment techniques, clinical judgment, negative patient/client reactions,
alternative treatment procedures/techniques, and methods frequently used for obtaining
informed consent. (Tables 2, 3, 4, and 5 present psychologists’ attitudes in detail.).
Descriptive statistics that demonstrated commonly endorsed attitudes and practices
related to addressing negative treatment effects of psychotherapy during informed
consent are as follows:
An overwhelming majority of participants (97.1%) agreed that there are potential risks to
clients in engaging in psychotherapy (Strongly Agree=24.3%, Moderately Agree=34.0%,
and Slightly Agree=36.1%). It should be noted that 12 participants chose not to answer
this question. However, they completed the remaining demographic questions; therefore,
they were retained in the study. Similarly, the majority of participants (90%) agreed that
some psychotherapeutic treatment techniques produce a greater probability of potentially
negative treatment effects than others (Strongly Agree=35.7% and Moderately
Agree=38.6%). Participants’ attitudes related to the use of clinical judgment (evoking
therapeutic privilege) toward negative treatment effects were somewhat varied, with onehalf (50%) reporting disagreement with its use and significantly less (23.1%) in
agreement (Moderately Disagree=26.9%, Strongly Disagree=23.1% and Slightly
Agree=15.7%, Moderately Agree=6.7%, Strongly Agree=0.7%). A small portion
(14.9%) remained neutral and 23 participants chose not to answer the question. More
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than one-half of the participants (66.9%) reported no known negative reactions from
clients, relative to the informed consent process as a whole (Strongly Disagree=40.4%,
Moderately Disagree=26.5%). Twenty-one participants chose not to answer the question.
More than half (68.6%) of participants agreed that addressing potentially negative
treatment effects of psychotherapy during the informed consent process does not
negatively impact the therapeutic alliance and subsequent treatment outcome (Strongly
Agree=34.3%, Moderately Agree=34.3%, and Slightly Agree=12.4%). Twenty
participants chose not to answer the question. The majority of participants (89.4%)
agreed that a discussion of the risk, including potentially negative treatment effects
during informed consent, is of ethical importance (Of note, this was a negatively worded
question) (Strongly Disagree=69.9%, and Moderately Disagree=19.5%). Twenty-four
participants chose not to answer the question. The majority of participants disagreed
(53%) and a somewhat fewer number agreed (39.5%) that symptomology, personality,
and overall functioning impacts the therapeutic decision to address negative treatment
effects in psychotherapy (Strongly Agree=6.7%, Moderately Disagree=13.4%, Slightly
Agree=19.4%, and Strongly Disagree=19.4%, Slightly Disagree=20.9, Slightly
Disagree=12.7%). Twenty-three participants chose not to answer the question.
Similarly, participants’ attitudes were almost evenly split (48.6% endorsing disagreement
and 43.8% noting agreement) regarding informing clients at the onset of psychotherapy,
that therapy might not work for them and that they could become worse as a result of
engaging in psychotherapy (Strongly Agree=5.4%, Moderately Agree=14.6%, Slightly
Agree=23.8%, and Slightly Disagree=16.2%, Moderately Disagree=16.2%, Strongly
Disagree=16.2%). Twenty-seven participants chose not to answer the question.
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Interestingly, of 161 responses to the statement, “10 percent of clients get worse as result
of psychotherapy”, 41% endorsed a neutral attitude and 25 participants chose not to
answer this question.
When asked how important it was to address potentially negative effects of
psychotherapy during informed consent, almost half (48.3%) agreed about its importance,
but significantly fewer (19.6%) did not (Very Important=28.0%, Moderately
Important=23.1%, Slightly Important=18.2%, and Very Unimportant=10.5%, Moderately
Unimportant=6.3%, Slightly Unimportant=2.8%). (See Table 2). It should be noted that
14 participants chose not to answer this question. A discussion of alternative
treatment/procedures (including no treatment) was rated important during informed
consent by 41.2% participants, and somewhat less important by 18% of the sample (Very
Important=28.0%, Moderately Important=24.5%, Slightly Important=14.7%, and Very
Unimportant=9.8%, Moderately Unimportant=10.5%, Slightly Unimportant=7.7%). (See
Table 3). Fourteen participants chose not to answer this question. Approximately onethird (34.1%) of the sample reported beginning the discussion of informed consent prior
to the first session of psychotherapy; more than half (58.0%) reported starting the
discussion during the first session, and significantly fewer (6.5%) reported a discussion of
informed consent on an as-needed basis or not at all. Nineteen participants chose not to
answer this question (See Table 4). Finally, the most common methods of assessment for
overall progress in psychotherapy include: use of outcome measures and questionnaires
(84.0%), asking the client directly (72.5%), and giving and receiving feedback (65.1%)
(See Table 5 for details). It should be noted that more than one category could be rated
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for this question; therefore, some participants rated more than one method of assessment
and 23 participants chose not to answer this question.
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Table 2
Frequent Attitudes Endorsed on the Survey Questionnaire
________________________________________________________________
Attitudes

Percentage

________________________________________________________________
There are potential risks to clients engage in psychotherapy.
Strongly Agree

24.3

Moderately Agree

34.0

Slightly Agree

36.1

Neutral

1.4

Slightly Disagree

0.0

Moderately Disagree

2.8

Strongly Disagree

1.4

Some psychotherapeutic treatment techniques produced a greater probability of
potential negative effects than others.
Strongly Agree

35.7

Moderately Agree

38.6

Slightly Agree

15.7

Neutral

4.3

Slightly Disagree

1.4

Moderately Disagree

4.3

Strongly Disagree

0.0

________________________________________________________________
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Table 2-cont.
Frequent Attitudes Endorsed on the Survey Questionnaire
________________________________________________________________
Attitudes

Percentage

________________________________________________________________
There are times when my judgment about a client prevents me from addressing
negative effects of psychotherapy during the informed consent process.
Strongly Agree

0.7

Moderately Agree

6.7

Slightly Agree

15.7

Neutral

14.9

Slightly Disagree

11.9

Moderately Disagree

26.9

Strongly Disagree

23.1

My clients have reacted negatively during the informed consent process.
Strongly Agree

0.0

Moderately Agree

2.2

Slightly Agree

9.6

Neutral
Slightly Disagree

12.5
8.8

Moderately Disagree

26.5

Strongly Disagree

40.4

________________________________________________________________
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Table 2-cont.
Frequent Attitudes Endorsed on the Survey Questionnaire
________________________________________________________________
Attitudes

Percentage

________________________________________________________________
Addressing potential negative effects of psychotherapy during the informed consent
process does not negatively impact the therapeutic alliance and subsequent treatment
outcome.
Strongly Agree

34.3

Moderately Agree

34.3

Slightly Agree

12.4

Neutral

10.2

Slightly Disagree

2.9

Moderately Disagree

2.9

Strongly Disagree

2.9

________________________________________________________________
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Table 2-cont.
Frequent Attitudes Endorsed on the Survey Questionnaire
________________________________________________________________
Attitudes

Percentage

________________________________________________________________
During the informed consent process, a client’s current symptomology, personality,
and overall functioning, impacts whether or not to address potentially negative effects
of engaging in psychotherapy.
Strongly Agree

6.7

Moderately Agree

13.4

Slightly Agree

19.4

Neutral

7.5

Slightly Disagree

12.7

Moderately Disagree

20.9

Strongly Disagree

19.4

________________________________________________________________
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Table 2-cont.
Frequent Attitudes Endorsed on the Survey Questionnaire
________________________________________________________________
Attitudes

Percentage

________________________________________________________________
It is unethical to include a discussion of risk of potential negative effects of
psychotherapy during the informed consent process.
Strongly Agree

0.8

Moderately Agree

0.8

Slightly Agree

0.0

Neutral

2.3

Slightly Disagree

6.8

Moderately Disagree

19.5

Strongly Disagree

65.9

________________________________________________________________
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Table 2-cont.
Frequent Attitudes Endorsed on the Survey Questionnaire
________________________________________________________________
Attitudes

Percentage

________________________________________________________________
At the onset of therapy I always tell my clients not only the therapy might not work
for them, but that they could become worse as a result of engaging in psychotherapy.
Strongly Agree

5.4

Moderately Agree

14.6

Slightly Agree

23.8

Neutral

7.7

Slightly Disagree

16.2

Moderately Disagree

16.2

Strongly Disagree

16.2

Approximately 10% of clients get worse as a result of engaging in some aspects of
psychotherapy.
Strongly Agree

2.3

Moderately Agree

12.1

Slightly Agree

13.6

Neutral

41.7

Slightly Disagree
Moderately Disagree
Strongly Disagree

9.1
11.4
9.8
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Table 3
Frequent Attitudes Endorsed on the Survey Questionnaire
________________________________________________________________
Attitudes

Percentage

________________________________________________________________
How important is it to you to address potential negative effects of psychotherapy
during the informed consent process?
Very Unimportant

10.5

Moderately Unimportant

6.3

Slightly Unimportant

2.8

Neutral

11.2

Slightly Important

18.2

Moderately Important

23.1

Very Important

28.0

How important is it to you to inform clients of alternative treatment/procedures
(including no treatment) during the informed consent process?
Very Unimportant
Moderately Unimportant

9.8
10.5

Slightly Unimportant

7.7

Neutral

4.9

Slightly Important

14.7

Moderately Important

24.5

Very Important

28.0
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Table 4
Frequent Attitudes Endorsed on the Survey Questionnaire
_______________________________________________________________
Attitudes

Percentage

_______________________________________________________________
At what point during the therapeutic process do you usually began a discussion
of informed consent?
Before the First Session

34.1

During the First Session

58.0

During the Second Session

0.7

During the Third Session

0.7

After the Third Session

0.0

On an “As Needed” Basis

5.1

Never

1.2

________________________________________________________________
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Table 5
Frequent Attitudes Endorsed on the Survey Questionnaire
________________________________________________________________
Attitudes

Percentage

________________________________________________________________
What methods do you most commonly use to assess your patient/clients’
overall progress in therapy?*
Questionnaires

43.0

Outcome Measures/Assessments

51.0

Asking the Client

72.5

Giving and Receiving Feedback

65.1

_________________________________________________________________
*Participants were able to rate more than one choice.
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Results of Hypotheses Testing
It was predicted that licensed psychologists would be more likely to inform clients
of risk associated with potentially negative treatment effects as a result of engaging in
psychotherapy, if they acknowledge the significance of those negative effects. The first
hypothesis stated there would be a correlation between attitudes toward negative
treatment effects and acknowledgement of the potential risks to clients involved. A twotailed Pearson product-moment correlation was used. Results failed to support this
hypothesis as an inverse relationship, r(141) = -0.254, p < 0.01, two tailed, was found.
Licensed psychologists are less likely to address negative treatments of psychotherapy if
they acknowledge the existence of those risks.
It was also predicted that licensed psychologists might be hesitant to address
potentially negative effects of psychotherapy due to the belief that it will negatively
affect therapeutic alliance and subsequent therapy outcome. The second hypothesis
stated that attitudes toward addressing negative effects would be rated less important if it
was perceived to adversely affect therapeutic alliance and subsequent treatment outcome.
A one-tailed Pearson product-moment correlation revealed an inverse relationship, r(136)
= -0.228, p < 0.01, one tailed. Results failed to support this hypothesis because attitudes
toward negative effects are rated as being important to address during informed consent;
however, they are not thought to impact therapeutic alliance and treatment outcome
negatively. Further, there was an inverse correlation found relative to the importance of
addressing potentially negative treatment effects of psychotherapy during informed
consent and to informing clients of the potential of therapy ineffectiveness and/or
becoming worse, r(128) = -0.283, p < 0.01, two tailed. These results suggest a
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discrepancy between attitudes toward informed consent procedures and implementation
during the informed consent process.
The third hypothesis predicted that years of clinical experience, post-doctoral
ethics training, and a Cognitive-behavioral orientation, respectively, would correlate with
attitudes related to informed consent practices, specifically with regard to discussion of
risks related to negative treatment effects.
Clinical experience and attitudes. It was expected that years of clinical
experience as a licensed psychologist would correlate with attitudes and practices related
to addressing risk during informed consent; however, results of a two-tailed Pearson
product-moment correlation revealed no significant findings.
Post-doctoral ethics training and attitude. It was expected that those who
received post-doctoral training in ethics and informed consent, would be more likely to
include a discussion of risk of potentially negative treatment effects as part of informed
consent practice. A one-way between subjects analysis of variance (ANOVA), at the
p<0.05 level, revealed a difference between the mean score of those who received postdoctoral ethics training (M=1.95, SD=1.07) and mean score of those who did not
(M=2.54, SD=1.47), F (1, 120) = 4.99, p = 0.027, in support of the hypothesis.
Participants who received post-doctoral ethics training are more likely to agree that some
therapeutic treatment techniques produce greater probability of risk of negative effects
than others. A marginally significant relationship was found, using a one-way between
subjects analysis of variance (ANOVA), at the p<0.05 level, between mean score of those
who received post-doctoral ethics training (M=6.65, SD=0.85) and mean score of those
who did not (M=6.25, SD=1.11), related to attitude toward ethical importance of a
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discussion of risk of potential negative treatment effects during the informed consent
process, F (1, 119) = 3.70, p = 0.056. Results suggest that those who receive ethics
training are more likely to agree with the ethical importance of addressing negative
treatment effects during informed consent.
Orientation and attitudes. It was expected that therapeutic orientation,
specifically Cognitive-behavioral orientation, would be related to attitudes and practices
toward addressing negative treatment effects during informed consent; however, results
of a one-way between subjects analysis of variance (ANOVA), at the p<0.05 level,
revealed no significant findings. Licensed psychologists from a Cognitive-behavioral
orientation were no more likely to rate the importance of addressing negative treatment
effects during informed consent than those from other therapeutic orientations.
Although no original hypothesis were made, a one-way between subjects analysis
of variance (ANOVA), at the p<0.05 level, was run to find out if degree (Ph.D. versus
Psy.D.), or if gender, and age were related to attitudes and practices of informed consent,
specifically related to importance in addressing negative treatment effects as part of a
discussion of risk.
Degree versus attitudes and practice. A significant result was found between
means of those who hold a Ph.D. degree (M=4.74, SD=2.07) versus Psy.D. degree
(M=5.71, SD=1.61) in regard to attitudes and practices of informing clients of alternative
treatment/procedures (including no treatment) during the process of informed consent, F
(1, 129) = 4.18, p = 0.043. Those licensed psychologists who hold a Psy.D. degree rated
informing clients of alternative treatments/procedures (including no treatment), during
the process of informed consent, as more important than those who hold a Ph.D. degree.
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Gender versus attitudes and practice. A significant correlation was found
between means for licensed psychologist males (M=2.19, SD=1.47) and licensed
psychologist females (M=1.69, SD=1.68) related to attitudes and practices toward the
initial discussion of informed consent in psychotherapy, F (1, 129) = 5.88, p = 0.017.
Results suggest that licensed psychologist females are more likely to begin the discussion
of informed consent before or during the first session, but licensed psychologist males
begin the discussion between the first and second session of psychotherapy.
Age versus attitudes and practice. Analysis for age and attitudes and practices
of informed consent procedures revealed no significant findings, which suggests that a
licensed psychologist’s age does not correlate with attitudes and practices related to
informed consent practices.
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Chapter Six: Discussion
Summary of the Study Rationale
The current survey study investigated the relationship between attitudes and
practices toward addressing risk of potential negative treatment effects of psychotherapy
during the process of informed consent. Because of the potential of psychotherapy to
produce risks of negative treatment effects, there are implications in clinical practice for
informed consent procedures (Bergin, 1971; Boisvert & Faust, 2003; Lambert & Ogles,
2004; Lilienfeld; 2007; Mercer, Sarner, & Rosa, 2003; Mohr, 1995; Stricker, 1995;
Strupp, Hadley, & Gomes-Schwartz, 1977). The rationale for this study is rooted in the
Ethics Code (2002), which includes broad guidelines for obtaining informed consent to
psychotherapy, including informing clients early on of the dynamics of treatment,
potential risks, and of alternative treatments that may be available. Although the Ethics
Code (2002) refers specifically to the importance of informed consent with treatments
that lack evidence-based efficacy, it is ethically and morally consistent with the
fundamental concepts of informed consent to include a discussion of potential risk of
negative treatment effects associated with psychotherapy (Barden, 2001, Boisvert &
Faust, 2003; APA, 2002). It is known that clinical research tends to have more stringent
criteria to abide by the Ethics Code (2002); however, little is known about practicing
psychologists’ attitudes and subsequent clinical practices related to addressing risk of
negative treatment effects. Because research is not well developed in this area, a survey
design was used for the study. Further, the study intended to explore general questions
related to ethics, attitudes and practices in addressing risks of potential negative treatment
effects of psychotherapy, including whether or not alternative treatments and/or
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procedures are used, during the process of informed consent. The relationship between
years of formal training, theoretical therapeutic orientation, and invoking therapeutic
privilege (use of clinical judgment) during informed consent was also assessed. Findings
for the current study suggest that opinions and practices regarding the application of
informed consent, specifically related to addressing potential risk of negative treatment
effects associated with psychotherapy, vary with characteristics of licensed psychologists.
This is the first study known to quantify the attitudes and practices of licensed
psychologists on this subject. Several significant findings were discovered from the data
analysis.
Demographic Information
It is noteworthy that the demographic data obtained for the current survey study is
a close match to a nationwide sample (N=272) of licensed practicing psychologists
(Greenbury & Jesuitus, 2002). In their survey study, primary ethnicity was Caucasian
(93.2%), almost evenly split male (48.5%) and female (50.7%). The majority held a
Doctor of Philosophy degree (Ph.D.=77.5%, Psy.D.=13.9%, Ed.D.=0.04%), with primary
emphasis in clinical psychology (50-57%), with counseling (4-7%) rated significantly
less. Both primary and secondary orientation included, Cognitive/Behavioral (57%),
Interpersonal (14%), Psychodynamic (11%), and somewhat fewer, Behavioral (6.5%).
Primary work setting included Human Services (70%) and Educational/School (15%).
Finally, 93% reported that they did not hold an American Board of Professional
Psychology specialty certificate (Greenbury & Jesuitus, 2002). Because the demographic
information was closely matched to a national sample, it could be inferred that the results
of this study are representative of practicing psychologists in the United States.
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Relationship between Attitude and Practice
Research revealed that licensed psychologists, who recognize risks of potential
negative treatment effects from engaging in psychotherapy, are less likely to address
potential risk during the informed consent process. These findings reveal a discrepancy
between attitudes toward informed consent procedures and the implementation of
informed consent practice. It should be noted that potentially negative treatment effects
occur as a result in engaging in psychotherapy and does not mean clinical incompetence.
Although licensed psychologists in this study generally agreed that potential risk of
negative treatment effects are important enough to be discussed during informed consent,
there is little evidence to support adequate implementation into the clinical setting. The
majority of licensed psychologists shared similar opinions regarding the ethical
importance of addressing negative treatment effects during the process of informed
consent. These congruent attitudes centered on the existence of potential risks of
engaging in psychotherapy, and that there are some treatment procedures which have
greater potential to produce negative treatment effects than others. Contrary to
expectation, discussion of potential risk of negative treatment effects were generally not
thought to adversely impact therapeutic alliance and subsequent treatment outcome. In
the clinical setting, however, there is some variability among licensed psychologists'
practices relative to addressing informed consent of potential risk. Licensed
psychologists did not rate invoking therapeutic privilege (using clinical judgment),
potential deterioration effects and ineffective psychotherapy, personality factors and
overall functioning as potential variables that affect therapeutic decisions to include a
discussion of risk as part of informed consent. These finding are supported by Pope,
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Tabachnick, and Keith-Spiegel (1987) who discuss “self-reported behavioral norms are
not the same as ethical standards” (as cited in Somberg, Stone, & Clairborn, 1993). The
apparent variability may be attributed to the complexity of factors which impact the
process of obtaining informed consent for a specific issue. The data does not support the
notion that licensed psychologists practice in accordance with their attitudes toward
addressing risk of negative treatment effects during informed consent. This conclusion is
not reflected in the literature on informed consent practices and ethical issues.
A possible explanation for the discrepancy between attitudes toward informed
consent procedures and implementation of informed consent practice might be related to
vague guidelines outlined in the Ethics Code (2002). Although the code is intended to be
used as a guideline for standards and professional conduct, personal attitudes about ethics
and implementation of informed consent practice appear to vary widely. Because of
ambiguous ethical guidelines, the addressing of potential risk during informed consent is
susceptible to individual interpretation (Pomerantz, 1998). Walker et al. (2005) note that
informed consent with psychotherapy appears less clear, due to the nature of the consent
process, which tends to take place over a period of time. As a guiding principle,
information that is material to the particular client’s decision is needed in informed
consent discussions (Beahrs & Gutheil, 2001). Although the level of detail varies
depending on the costs, the risks of the proposed treatment, viable alternatives,
professional acceptance and the fact that it is research-based, the question remains how to
address “problematic or controversial psychotherapeutic trends that temporarily enjoy
wide professional support” (Beahrs & Gutheil, 2001, p. 4). Lack of clear and distinct
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outlines for informed consent procedures related to addressing risks of negative treatment
effects, may account for licensed psychologists’ contradicting views.
There is another possible reason that licensed psychologists report that they agree
with engaging in psychotherapy that has the potential to produce negative treatment
effects, but do not include a discussion of risk during informed consent; this reason
involves the limitations of humans as information processors and may suggest cognitive
biases (e.g. Dawes, Faust, & Meehl, 1989; Lutz et al., 2006). The potential biases may
limit the degree to which clinicians can accurately assess whether or not client outcome
will be a success or failure. Another possible explanation may be that clinicians might
simply not trust their clients’ decisions or abilities to make choices about
psychotherapeutic treatment. Twenty-three percent of surveyed licensed psychologists
reported that they use clinical judgment (evoking therapeutic privilege) when addressing
risk toward negative treatment effects. There is, however, no known evidence to suggest
that clients informed about risks of engaging in psychotherapy cannot make informed
decisions about treatment (in the absence of clear incompetence) (Walker et al., 2005).
In fact, Jensen and MacNamara (1991) suggest that disclosure about potential risks
during informed consent appears to have no negative effect on client decision to engage
in psychotherapy. Similarly, Handelsman (1990) reported that there is no empirical
evidence to support adverse effects as a result of informing clients about risk that is
related to psychotherapy during informed consent. In light of evidence-based practice,
the Institute of Medicine (2001) states that the process of informed consent must include
an “integration of best research evidence with clinical expertise and patient values” (p.
146). The process of informed consent is intended to combine clinical knowledge with
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client participation, while assuming an ethical and moral obligation to provide a detailed
explanation of potential risks of negative treatment effects. Another key expectation for
informed consent includes respect for autonomy and the fact that informed consent is
considered an on-going process throughout the psychotherapy experience. Walker et al.
(2002) suggest that informed consent, at a minimum, must contain disclosure of potential
risks and benefits and address particular recommended alternative treatment.
Contrary to expectation, no significant differences were found in regard to the
extent that years of clinical experience, theoretical therapeutic orientation, and the age of
those practitioners impact attitudes and practices related to addressing risk of negative
treatment effects during informed consent. Although research indicates that some
orientations may lend themselves more closely toward informed consent than others,
because they consider issues “more important” (e.g., CBT treatment possesses a highly
structured manualized approach) (Somberg et al., 1993, p. 153), results from this survey
revealed orientation does not impact the decision about whether or not licensed
psychologists inform clients of potential risks in treatment. This finding is supported by
both Dsubanko-Obermayr and Baumann's (1998) and Tymchuk, Drapkin, MajorKingsley, Ackerman, Coffman, and Baum’s (1982) survey studies, both of which
produced similar results. The finding that years of clinical experience does not correlate
with attitudes or practices of addressing potential risk during informed consent is
similarly supported by Boisvert and Faust's (2003) study (see section Informed Consent
and Risk).
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Implications for Informed Consent Practice
In the clinical setting, a conversation of risk that is related to potentially negative
treatment effects as a result of engaging in psychotherapy has received limited attention,
but is nonetheless important on ethical and moral grounds (see Ethics Code, 2002). On a
practical level, these arguments for addressing risk have potential implications related to
the conduct of clinical practice protocols. According to the Ethics Code's (2002)
informed consent standards, licensed psychologist should be given clinical guidelines.
The specifics of “viable alternatives” and “their relative grounding in scientific data and
professional acceptance” during a proposed treatment remains unresolved (Beahrs &
Gutheil, 2001). Risks and benefits are clearly discussed when psychotropic medications
are prescribed, “due to pharmacological side effects”; however, Walker et al. (2005)
noted that it is less the case with psychotherapy alone (p. 241). Although potential risk
from verbal therapies might appear to have less visible impact, research reveals they are
considered just as important to include during informed consent, as are the potential
medical risks (Walker et al., 2005; Berg et al., 2001). As previously mentioned, Thyer
and Myers (1998) assert that clients are entitled to information related to evidence-based
psychological treatment. However, as research has noted, even the most effective and
efficacious psychotherapeutic treatments do not work for everyone, which emphasizes
the importance of including a discussion of potential risk that is related to negative
treatment effects during the informed consent process.
In order to assess treatment that is not working, Lambert and his colleagues
(2003) studied client feedback in psychotherapy, including its impact on outcomes. In
order to detect improvement, prior to the beginning of each psychotherapy session,
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feedback regarding therapy was elicited from the clients and subsequently compared with
average progress made by similar norms (onset and symptom severity). Results
demonstrated that providing clinicians with feedback had beneficial effects on
psychotherapy outcomes. Lambert et al. (2003) reported sole reliance on pure clinical
judgment to identify and make treatment decisions was insufficient. One of the main
reasons that client feedback had such a dramatic effect on outcomes, Lambert et al.
(2003) assert, is that, without this information, psychotherapists seldom expect their
clients to become worse. Lambert et al. (2003) equated measuring client outcomes to
having one’s blood pressure taken in medicine. Obtaining tangible mental health vital
signs can be used as a gauge for psychotherapy. Roth and Fonagy (2004) report the fact
that therapists often ignore signs that clients are not benefiting from psychotherapy due to
biases in thinking. Tracking progress would be beneficial in ensuring psychotherapists’
awareness of outcomes. In order to assess psychotherapy treatment, an awareness of
informed consent and negative treatment effects is essential. Teaching critical thinking
and facts regarding psychological disorders is paramount (Lilienfeld, 2007). Lilienfeld
(2007) asserted that a careful understanding of biases and heuristics can impact and
influence one’s judgment into thinking that certain techniques or treatments are working,
when in fact they are not.
Results from this study could have potential implications, for example, in
establishing better comprehensive, informed consent guidelines for practitioners. Half of
the participants surveyed, for example, either remained neutral or did not rate the survey
question: “Approximately 10 percent of clients get worse as a result of engaging in some
aspect of psychotherapy” (See Table 2). Although the reasons about why this particular
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question was ignored are unknown, it could be argued that practitioners are unfamiliar
with knowledge from psychotherapy research on potential risk of negative treatment
effects in psychotherapy. Thus, they may be relying on personal opinions rather than on
evidence-based research. It seems essential that in order to apply science to
psychotherapy, an understanding of findings about research on negative treatment effects
would be considered paramount to practical application.
Method for obtaining progress in psychotherapy. The method most commonly
used to inform clients of overall progress in psychotherapy was outcome measures and
questionnaires. The other methods reported were asking the client directly, and giving
and receiving feedback. The use of outcome measures and questionnaires have their
advantages (documentation, standardization of treatment, fewer liability concerns);
however, it is interesting that verbal communication was not in greater use. The available
empirical data suggest a combination of both verbal and written methods are best practice
in assessing overall progress.
Timing of informed consent procedures. Although approximately one-third of
the participants reported starting a discussion of informed consent prior to the first
session of psychotherapy, more than half reported starting the discussion during the first
session, and significantly fewer reported a discussion of informed consent on an “asneeded” basis or not at all. Interestingly, female licensed psychologists are more likely to
begin the discussion of informed consent before or during the first session, but male
licensed psychologists begin the discussion between the first and second sessions of
psychotherapy. Although early presentation of informed consent factors might be ideal, a
conversation of risks related to negative treatment effects might argue for greater
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flexibility. In one study, Pomerantz (2005) surveyed licensed psychologists regarding the
“earliest feasible point at which they could provide information regarding specific aspects
of therapy” (p. 351). Results found more substantial information, such as potential risks,
could be presented only after some engagement in psychotherapy. Reasons for
participants informing clients on an “as-needed basis” or “not at all” are unclear. If,
however, a specific therapeutic treatment/procedure has not yet been identified, it seems
premature to expect licensed psychologists to inform clients of potential risks of negative
treatment effects as a result in engaging in psychotherapy. Appelbaum, Lidz, and
Meisel's (1987) process model of informed consent (see Chapter 2) would provide greater
flexibility if it viewed the informed consent process as continuous throughout the entire
course of psychotherapy treatment rather than as a one-time event. Although this survey
study did not inquire about the kind of model that licensed psychologists use, the answers
themselves appear to be within the context of a one-time event model. Similarly,
although most of the sample agreed that it is important to address risk of potential
negative treatment effects, the survey did not inquire about a time when those potential
risks are initially presented.
Post-Doctoral Ethics Training and Attitudes of Risk. Data from this study
suggest licensed psychologists who report receiving post-doctoral ethics training are
more likely both to agree that some therapeutic treatment techniques have greater
probability of producing risk of negative effects than others, and to agree to the ethical
importance of addressing potential risk of negative treatment effects during informed
consent. Results, however, did not find that those who reported having had post-doctoral
ethics training were more likely to inform clients of potentially negative treatment
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effects. These findings are consistent with other research which suggests that there is
little consistency between ethical decision-making and psychologists' attitudes toward
training in ethics (Tymchuk et al., 1982). Licensed psychologists may have a limited
understanding of the importance of post-doctoral training in ethics as it relates to
informed consent practices that subsequently impact clients engaging in psychotherapy.
Researchers strongly believe that it is important for clinical practice to be influenced by
outcome research; Bohart (2000), however, notes that it is another thing for practice to be
dictated by findings from clinical research.
Degree and attitudes. Research revealed that licensed psychologists who hold a
Psy.D. degree rate informing clients about alternative treatments and/or procedures
(including no treatment) during the process of informed consent, as more important, than
those who hold a Ph.D. degree. The primary emphasis placed on a Psy.D. degree
involves clinical practice and on training practitioners to be consumers of research.
Research has substantiated the fact that, unlike the Ph.D. degree (Boulder-model) with an
emphasis to produce research, the Vail-model Psy.D. programs provide slightly more
clinical experience and clinical courses, but with less research experience (Tibbits-Kleber
& Howell, 1987). Although there appears to be little difference in employment
opportunities, graduates from research-oriented Ph.D. programs are more likely to be
employed in academic positions and in medical schools (Gaddy, Charlot-Swilley, Nelson,
& Reich, 1995). Thus it could be argued that psychologists with Psy.D. Degrees may be
more likely to be practicing psychotherapists and have greater clinical exposure with
informed consent procedures related to risks. Those psychologists who hold Psy.D.
Degrees may also have more experience in the clinical application of informed consent
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related to addressing alternative treatments and/or procedures (including no treatment)
during the informed consent process.
Limitations and Implication for Future Research
Several limitations to the present study are apparent; this is evident with any
research methodology. First, the sample of licensed psychologists pooled belongs to the
National Directory of Psychologists, the Association of Black Psychologists, and
graduate school psychology programs listed on the APA directory. Licensed
psychologists with posted electronic mail addresses on these directories may possess
unique characteristics which may affect their responses, in comparison with licensed
psychologists who are not members of those websites and directories.
Another limitation involves the selection of subjects. Licensed psychologists with
electronic mail addresses posted on websites may possess unique characteristics which
can limit generalizability to the entire population of psychologists. Most of the
participants were either in academic settings or in solo private practice (or both).
Consequently, the selection of subjects may be a threat to external validity. Furthermore,
nearly all the participants were Caucasian, which may also limit how well the results
represent the overall population of psychologists across the United States. Another
demographic characteristic that is considered a limitation is the type of degree, Ph.D.
versus Psy.D. of the sample. The majority holds a Ph.D.; therefore, they may have
responded differently from psychologists who hold a Psy.D. or an Ed.D. Degree.
Also, the present study relied solely on self-report measures which are associated
with a few major problems (Kazdin, 2003). Respondents may distort their answers in a
biased fashion because of the tendency toward giving socially desirable answers. The
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current study attempted to offset this limitation by including reassuring statements that
the survey is completely anonymous and voluntary. It is noteworthy that estimates of
licensed psychologists’ attitudes, not their actual practices were assessed. The attitudes
obtained may represent upper estimates of the reality of addressing potential risk of
negative treatment effects associated with psychotherapy. Feedback from participants in
the survey revealed they had difficulty rating only one modality of therapy (Question 24).
It is also important to note that the sample consisted of licensed doctoral level
psychologists and did not include those from other specialties. Results were based on
participants' attitudes and practices at the time of the measurement and because attitudes
are dynamic, actual practices may vary considerably from self-reports or opinions
(Croarkin et al. 2003). The other problem that characterizes self-report measures is the
lack of evidence that the questionnaire measures the construct of interest (Kazdin, 2003).
This newly formed questionnaire is the only survey of its kind found in the literature.
Therefore, comparisons could not be made with other research surveys regarding the
constructs of interest.
More research is needed to gain insight into how licensed psychologists
understand and practice addressing potential risk related to negative treatment effects
associated with psychotherapy. For example, it is unclear whether or not addressing
negative treatment effects during informed consent affects how clients view treatment
and subsequent outcome. Further, there is extremely limited research that describes the
practice of informed consent related to addressing risk of negative treatment effects.
Addressing risk of negative treatment effects in the clinical context and its influence on
psychotherapy outcome remains unknown. Future research might investigate the impact
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of addressing, early in the process of informed consent, potential risk of negative
treatment effects and the implications on treatment outcome. In addition, future research
might investigate psychologists' attitudes toward informing clients of potentially negative
effects with psychological assessment. Although controversial, some projective tests
(Rorschach inkblot test and Thematic Apperception Test) lack empirical support.
Research has found that these tests are not invalid; however, the norms and decision rules
tend to pathologize healthy individuals (Wood, Garb, Lilienfeld, & Nezworski, 2002). In
fact, Wood et al. (2002) reveal that 70 percent of pathology- free individuals will
demonstrate serious disturbance on these measures. Future research might investigate
informed consent practices in the forensic setting, specifically, those regarding
psychological evaluations and their potential to produce negative outcomes and lifealtering consequences.
Conclusion
The apparent variability among licensed psychologists’ self-reported attitudes and
practices, suggest that sole reliance on standards outlined in the Ethics Code (2002) might
not be enough for clinical implementation regarding risk related to negative treatment
effects associated with psychotherapy. The informed consent process related to
addressing potential risk of negative treatment effects must be tailored to the unique
context of a particular psychotherapeutic treatment. This study underscores the inherent
complexity of applying ethical standards and principles to informed consent procedures
related to risks of negative treatment effects as a result of engaging in psychotherapy.
Although the phenomenon of risk, related to negative treatment effects appears
convoluted, this survey study intended to both acknowledge the significance of the
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problem and add to the limited body of research on practical applications of informed
consent practice.
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APPENDIX A
(Electronic mail message sent for participant solicitation and recruitment purposes)
Dear Volunteer/Doctor:
My name is Neshe Sarkozy; I am a Doctoral Candidate in the APA accredited Clinical
Psychology program at the Philadelphia College of Osteopathic Medicine (PCOM). I
am doing a survey research study on attitudes and practices of licensed psychologists
related to the informed consent process. By participating you may feel some personal
satisfaction having taken part in research that may improve the ethical practice of
informed consent implementation. I would be grateful if you would complete the
questionnaire at the following URL address:
http://www.surveymonkey.com/s.aspx?sm=dSDV2FSbARlZFjKu6_2bB4lA_3d_3d
Completion of the questionnaire is expected to take about 10 minutes.
Participation in this project is voluntary and you are not asked any identifying
information. If you would like to take part in this survey study, please click NEXT at
the beginning of the survey and it will automatically prompt you through to the
questionnaire. Should you have any comments or concerns resulting from your
participation in this survey study, you can also contact PCOM’s Research Compliance
Specialist at 215-871-6782. Thank you for your time and interest in this research
project.
Respectfully,
Neshe Sarkozy, M.A., M.S. Responsible Investigator
Ginny Burks Salzer, Ph.D. Principal Investigator, Associate Professor
Director of Clinical Psychology Research
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APPENDIX B
SURVEY QUESTIONNAIRE
Dear Participant,
All your responses will be kept confidential and you will not be identified in any way.
You will be able to opt out of the survey at any time by simply exiting the survey.
1) Are you licensed for independent practice as a psychologist?
o

Yes

o

No

If you have answered YES, please complete the following survey. Thank you in advance.

Instructions: For purposes of this study, client harm (negative effects) caused by some
aspect of psychotherapy include; no change or benefit, excessive concern over worsening
or new symptoms, excessive dependency on therapist, reluctance to seek future treatment,
client abuse or misuse of psychotherapy, or physical harm.

2) There are potential risks (negative effects) to clients engaging in psychotherapy.
o

Strongly Agree

o

Moderately Agree

o

Slightly Agree

o

Neutral

o

Slightly Disagree

o

Moderately Disagree

o

Strongly Disagree

INFORMED CONSENT IN PSYCHOTHERAPY
3) How important is it to you to address potential negative effects of psychotherapy
during the informed consent process?
o

Very Unimportant

o

Moderately Unimportant

o

Slightly Unimportant

o

Neutral

o

Slightly Important

o

Moderately Important

o

Very Important

4) How important is it to you to inform clients of alternative treatment/procedures
(including no treatment) during the informed consent process?
o

Very Unimportant

o

Moderately Unimportant

o

Slightly Unimportant

o

Neutral

o

Slightly Important

o

Moderately Important

o

Very Important
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5) At what point during the therapeutic process do you usually begin a discussion of
informed consent?
o

Before the first session

o

During the first session

o

During the second session

o

During the third session

o

After the third session

o

On a “as needed” basis

o

Never

6) What methods do you most commonly use to assess your patient/client's overall
progress in therapy?
o

Questionnaires

o

Outcome measures/assessment

o

Asking the client

o

Giving and receiving feedback

o

None

o

Others: ____________
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7) Some psychotherapeutic treatment techniques produce a greater probability of
potential negative effects than others.
o

Strongly Agree

o

Moderately Agree

o

Slightly Agree

o

Neutral

o

Slightly Disagree

o

Moderately Disagree

o

Strongly Disagree

8) There are times when my judgment about a client prevents me from addressing
negative effects of psychotherapy during the informed consent process.
o

Strongly Agree

o

Moderately Agree

o

Slightly Agree

o

Neutral

o

Slightly Disagree

o

Moderately Disagree

o

Strongly Disagree
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9) My clients have reacted negatively during the informed consent process.
o

Strongly Agree

o

Moderately Agree

o

Slightly Agree

o

Neutral

o

Slightly Disagree

o

Moderately Disagree

o

Strongly Disagree

10) Addressing potentially negative effects of psychotherapy during the informed consent
process does not negatively impact the therapeutic alliance and subsequent treatment
outcome.
o

Strongly Agree

o

Moderately Agree

o

Slightly Agree

o

Neutral

o

Slightly Disagree

o

Moderately Disagree

o

Strongly Disagree
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11) During the informed consent process, a client’s current symptomology, personality,
and overall functioning, impacts whether or not to address potential negative effects of
engaging in psychotherapy.
o

Strongly Agree

o

Moderately Agree

o

Slightly Agree

o

Neutral

o

Slightly Disagree

o

Moderately Disagree

o

Strongly Disagree

12) It is unethical to include a discussion of risk of potential negative effects of
psychotherapy during the informed consent process:
o

Strongly Agree

o

Moderately Agree

o

Slightly Agree

o

Neutral

o

Slightly Disagree

o

Moderately Disagree

o

Strongly Disagree
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13) At the onset of therapy, I always tell my clients not only that therapy might not work
for them but they could become worse as a result of engaging in psychotherapy.
o

Strongly Agree

o

Moderately Agree

o

Slightly Agree

o

Neutral

o

Slightly Disagree

o

Moderately Disagree

o

Strongly Disagree

14) Approximately 10 percent of clients get worse as a result of engaging in some aspect
of psychotherapy?
o

Strongly Agree

o

Moderately Agree

o

Slightly Agree

o

Neutral

o

Slightly Disagree

o

Moderately Disagree

o

Strongly Disagree
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Demographic Information:

15) Gender:
o

Male

o

Female

16) Year of Birth: (Scroll down option for ages 1935 - 1985)

17) Ethnicity:
o

Caucasian

o

Black or African-American

o

Hispanic-American/Latino/a

o

Native-American/American Indian

o

Asian or Pacific Islander

o

Multiracial/Mixed

o

Other (please specify)

18) Highest terminal degree completed:
o

Ph.D.

o

Psy.D.

o

Ed.D.

o

Other (please specify)
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19) What is your Doctorate in? (Scroll down options)
o

Clinical

o

Counseling

o

Developmental

o

Experimental

o

Educational

o

Social

o

School

o

Industrial/organizational

o

Physiological

o

Environmental

o

Health

o

Family

o

Rehabilitation

o

Psychometrics and Quantitative

o

Forensic

o

Other (please specify)

20) Are you American Board of Professional Psychology (ABPP) Certified?
o

Yes

o

No
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21) What is your ABPP Certification Area(s)?
o

Behavioral

o

Clinical

o

Neuropsychology

o

Counseling

o

Family

o

Forensic

o

Group

o

Health

o

Psychoanalysis

o

Rehabilitation

o

School

o

Not certified by ABPP

o

Other (please specify)

22) Number of years working as a psychologist of in a closely related field.
o

Less than 5 years

o

5-10 years

o

11-15 years

o

16-20 years

o

21-25 years

o

26-30 years

o

More than 30 years
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23) Population treated. (check all that apply)
o

Child

o

Adolescent

o

Adult

o

Older Adult

24) Therapy modalities. (check all that apply)
o

Individual

o

Couple

o

Family

o

Group
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25) Primary work setting/location. (check all that apply)
o

Hospital (public or private)

o

Partial hospitalization

o

Treatment facility (Drug and Alcohol, Residential Treatment,
Rehabilitation)

o

Community Mental Health Center

o

Solo Independent Practice

o

Group Practice

o

Academia (College/University)

o

Research

o

Administration

o

School (public or private)

o

Managed care company

o

Correctional Facility

o

Retired

o

Other (please specify)
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26) Primary theoretical therapeutic orientation.
o

Behavioral

o

Cognitive-Behavioral

o

Existential/Humanistic

o

Psychodynamic

o

Social learning

o

Systems

o

Other (please specify)

27) Have you ever attended a post-doctoral training on ethics that included information
on the informed consent process?
o

Yes

o

No

The End. Thank you for your participation.

